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INTRODUCTION
Hemodynamic monitoring is the cornerstone of critical care, especially when the patient 
is unstable. It needs to be used with the perspective of tailoring treatment to physiology 
and the underlying disease process (1). Monitoring should be easy to apply and negative 
side eff ects should be limited. The results should be reliable and reproducible, not least 
because we also need to monitor response to therapy when cardiovascular insuffi  ciency 
has been identifi ed. One of the primary goals of hemodynamic monitoring is to alert the 
physician to impending cardiovascular crisis before organ or tissue injury ensues. 
In general, the adequacy of circulatory stability is judged by clinical assessment of 
parameters that we can measure, e.g., blood pressure, urine output, heart rate and se-
rum lactate concentration. However these are indirect clinical markers of systemic blood 
fl ow and, as such, they are unreliable estimates of overall hemodynamic status, during 
critical illness, irrespective of the experience of the assessing clinician (2, 3). The logic is 
obvious when one considers that since blood pressure is a regulated variable, a normal 
blood pressure does not necessarily refl ect hemodynamic stability or perturbation (4).
Early recognition of hemodynamic instability in combination with an understanding 
of the often complex underlying pathophysiology is therefore essential. The clinical art 
is, fi rst, to monitor the right parameters and, secondly, apply the right target values, 
which can vary according to age or underlying pathology. In critical illness these are not 
necessarily the same as normal values in health (5). Pediatric intensivists and anesthe-
siologists should be familiar with age-appropriate normal values and the physiological 
diff erences between adults and children.
Cardiovascular physiology of the pediatric patient
Diff erences in growth and development, as well as the pathophysiological response to 
illness mean that children should not be regarded as small adults and data obtained from 
adults cannot be easily extrapolated to children. Diff erent body proportions, a higher 
metabolic rate, and lack of compensatory reserve for respiratory or circulatory threats 
are examples of factors that should infl uence ones approach to critically ill children.
The cardiovascular system changes markedly at birth due to dramatic alterations in 
blood fl ow patterns. Under normal circumstances, the fetal circulation, with its reduced 
perfusion of the lungs and intra- and extra-cardiac shunts between the pulmonary and 
systemic circulations, transitions rapidly to an adult circulation. The precipitous fall in 
pulmonary vascular resistance and corresponding increase in pulmonary blood fl ow 
leads to increased left atrial fi lling and closing of the intra-atrial connection (foramen 
ovale). The left ventricular preload rises and the cardiac output increases to meet 
metabolic demands (6). In the fetus and newborn the left ventricle is fl attened and the 
right ventricle is dominant. Newborn babies have less compliant ventricles and there-
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fore have compromised diastolic function. They have a reduced response to inotropes, 
volume loading, and increased sensitivity to afterload. The immature heart has reduced 
contractile reserve and a depressed contractile response to exogenous administration 
of catecholamines.
After the separation of the systemic circulation from the low pressure placental circuit, 
systemic vascular resistance (SVR) and left ventricular afterload rise steeply in concert 
with each other. Hence, neonates at birth have little inotropic reserve. They also have re-
duced preload reserve in comparison with older children and adults. After the transition 
from fetal to neonatal circulation, the SVR starts to drop and stroke volumes and cardiac 
output rise (7). Stroke volume index (SVI) and cardiac index (CI) continue to increase 
until the age of 5 years. SVI is stable and CI decreases slightly beyond the age of 5 years. 
The SVR decreases in the fi rst decade, with the major increase followed by progressive 
decrease, occurring in the fi rst 48 hours after birth (7). In infancy and childhood the 
myocardium adapts progressively to its new loading conditions and develops increased 
reserve to β adrenergic stimulation.
The compensatory mechanisms to hemodynamic disease appear to diff er in children 
compared with adults. Adults with septic shock have decreased ejection fraction and 
increased cardiac output (CO) through ventricular dilatation and increased heart rate 
(8). Children with septic shock do not have ventricular dilatation (9). Therefore, the most 
important way of increasing CO in young children is to increase heart rate. However, 
there is a problem here. An adult can increase resting heart rate from 60 to 100 beats per 
minute, but a proportionate increase in an infant from 140 to 220 beats per minute is 
not sustainable. In adults with septic shock, the hyperdynamic state (‘warm shock’) is the 
hallmark of cardiovascular pathophysiology. In children the response is more heteroge-
neous (10). Only a small percentage of children who present with septic shock exhibit a 
hyperdynamic state, with diminished SVR that responds to vasopressor support without 
a decrease in CI (10). The main presentation in pediatric septic shock is a hypodynamic 
state (‘cold shock’) with low CO and a high SVR (11, 12).
Studies in man with septic shock suggest that low CO and/or low SVR is detrimental 
to organ perfusion and survival. Children with septic shock, who maintain a CI between 
3.3 and 6.0 L/min/m2, seem to have higher survival rate compared with those who have 
CI outside this range (12).
Hemodynamic monitoring of the pediatric patient
An important goal of hemodynamic monitoring is to be able to detect inadequate tissue 
perfusion and oxygenation at an early stage, long before it becomes detrimental. As a 
consequence, the monitor should prompt and guide resuscitation.
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Three key components in the physiology of oxygen delivery can be identifi ed: 1) 
uptake of oxygen in the lung; 2) transport and delivery of oxygen from the lung to the 
tissues; and 3) oxygen uptake and utilization by the tissues.
At present, devices available for bedside monitoring give limited information about 
these processes. Oxygen saturation (SO2), measured by continuous pulse oximetry (SpO2) 
and arterial blood gas analysis (SaO2)  provides information about the oxygen content 
of the blood (CaO2), providing we also know the hemoglobin concentration. This covers 
oxygen uptake. Oxygen delivery (DO2) and utilization are more diffi  cult to assess. DO2 
is the product of CaO2 and CO. However, at regional level, vascular resistance is a major 
factor. There is evidence that low CO is associated with increased morbidity and mortal-
ity (10).  Assessment of CO by means of clinical estimation is inaccurate (3), and invasive 
measurements in children are little used (13, 14). As an alternative to invasive measure-
ment of CO in adults, central or mixed venous oxygen saturation (SvO2) has been used as 
a surrogate for the adequacy of CO. In children with complex congenital heart disease or 
intra- and / or extracardiac shunts SvO2 is not a useful measure. Central venous or mixed 
venous oxygen saturation is also invasive and carries risks in small children. Volumetric 
indices of cardiac function (e.g., M-Mode, femoral artery thermodilution catheter) are 
used extensively in the adult intensive care unit (ICU) in order to derive oxygen delivery. 
However, in the pediatric ICU, intra- and extracardiac shunts may change their validity 
and relevance. Again, the risks accompanying the insertion of the catheters (e.g. arterial 
thrombosis) outweigh the potential benefi ts. Echocardiographic evaluation of CO is not 
consistently reliable because even in the hands of experienced operators the variation 
in measurements between and within individuals is large (15).Taken together, evalua-
tion of CO is much less straightforward in children, as it is in adults.
In order to assess tissue perfusion, a variety of measures are followed, including capil-
lary refi ll time (CRT), temperature, and serum lactate concentration. In circulatory failure 
there is a hierarchy in regional blood fl ow with diversion away from skin and muscles 
towards vital organs such as heart, brain, and kidneys. Thus monitoring skin perfusion 
could be an early marker of increased sympathetic activity and hypoperfusion. CRT is a 
useful clinical parameter during the acute assessment and resuscitation of dehydrated 
children (16, 17). It is non-invasive, easy to use, and cheap. Its use in the pediatric ICU 
however might be of limited value. The correlation with global hemodynamics is poor 
(18). Only a weak correlation exists between severely prolonged CRT and SVI and serum 
lactate concentration (18). In addition, confounding factors such as fever and use of 
vasoactive medications should be considered. Nonetheless, a dramatic change in this 
parameter should alert the clinician to the need for a more detailed hemodynamic as-
sessment of the patient.
Lactate metabolism and the prognostic value of high serum lactate concentration in 
the ICU patient are well documented (19-21). However, the relationship between lactate 
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and tissue perfusion is not always well defi ned (22-24); possibly due to the fact that 
measured lactate is not only the result of the balance between anaerobic production 
and clearance, but that it may also arise from sources other than hypoxic tissues (25). 
Overall, these macrocirculatory parameters are currently considered as insensitive mark-
ers of tissue perfusion (26). Ideal hemodynamic monitoring should provide information 
about whether cells are receiving suffi  cient oxygen to sustain cellular mitochondrial 
production of ATP. Two key elements are DO2 and the removal of waste products such 
as carbon dioxide (CO2). Important factors that determine DO2 are CO, blood hemoglo-
bin concentration, SO2 of the hemoglobin molecule, and convection and diff usion of 
oxygen from arterioles to cells. In critical illness, DO2 is often deranged, and many of the 
therapeutic interventions in the pediatric ICU (e.g., fl uid administration, blood transfu-
sion, inotropes, mechanical ventilation) are, ultimately, used to improve DO2. At present, 
no real-time monitoring tool for use at the bedside is available for tracking DO2.
The microcirculation as an essential hemodynamic compartment
Circulatory shock is defi ned as failure of the cardiovascular system to maintain eff ec-
tive tissue perfusion, causing cellular dysfunction and subsequent acute organ system 
failure if not restored promptly. Although it is the macrocirculation that distributes 
blood fl ow throughout the body, it is the microcirculation that is the critical component 
of the cardiovascular system that ensures regional blood fl ow to individual tissues. 
Optimal macrocirculation, however, is the obvious prerequisite for adequate microcir-
culatory perfusion. Nevertheless, restoration of global hemodynamics does not always 
mean that adequate regional tissue perfusion is achieved, especially in conditions of 
impaired autoregulation such as occurs during critical illness. Previous studies in adults 
with septic shock have shown that indices of microcirculatory blood fl ow can serve as 
early indicators of tissue hypoperfusion, and therefore provide timely information about 
the potential onset of multi-organ failure (27-29). In health, microvascular perfusion is 
controlled locally so that tissue blood fl ow and substrate delivery is maintained, despite 
changes in arterial pressure (30). The lower limit of such fl ow-autoregulation – from 
fi rst principles based on mean arterial pressure and other factors in Poiseuille’s equa-
tion – varies between organs, patients, disease state, metabolic activity, and associated 
vasoactive therapies. Thus, there is no absolute threshold in blood pressure that defi nes 
adequate organ perfusion among organs, between patients, or in the same patient over 
time (31). However, because arterial pressure is a primary determinant of organ blood 
fl ow, hypotension is always pathological. Measuring the adequacy of microcirculatory 
blood fl ow as a direct indicator of the success of the cardiovascular system to provide 
adequate oxygen and nutrients to the cells, can be regarded as an important extension 
of the measurement of systemic hemodynamic variables (32). However, several issues 
need to be addressed. These are: 1) the reliability and reproducibility of the measure-
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ment; 2) the identifi cation of the most relevant microcirculatory parameters which need 
to be determined; and 3) the prognostic value of these parameters in guiding therapy.
Bedside measurement of the pediatric microcirculation
The microcirculation plays a crucial role in the interaction between blood and tissue, both 
in physiological and pathophysiological states. Analysis of alterations in microvascular 
blood fl ow therefore provides a unique perspective of disease processes at microscopic 
level (33). Orthogonal Polarization Spectral (OPS) imaging is the fi rst hand-held imaging 
device that allows bedside visualization of the microcirculation. OPS imaging is based 
on the optical technique introduced by Slaaf et al. (34), where green polarized light is 
used to  illuminate the tissue area of interest, which at the bedside is usually the buccal 
or sublingual mucosa. The green light is absorbed by hemoglobin within the red blood 
cells (RBCs) in the microcirculation. The refl ected light is detected by an orthogonally 
placed analyzer which fi lters out surface refl ections in order to produce a high-contrast 
refl ected light image of fl owing RBCs within the microcirculation (35) (Figure 1).
OPS imaging has been assessed in several studies (36-40). Quantifi cation of images is 
now standardized (41), reproducible, and validated (42). The parameters that are used 
to quantify the images include: the microvascular fl ow index (MFI), a measure of convec-
tive fl ow; and the functional capillary density (FCD) or vessel density index (VDI), for 
Figure 1. The CYTOSCAN E-II consists of a probe with a small lens attached to a halogen light source 
with a polarizing fi lter (selecting at a wavelength of 540 nm ± 10 nm) and a dichromic mirror. The light 
travels from the lens to the tissue of interest. Refl ected light is fi ltered out by the analyzer and light that 
penetrates the tissue will be depolarized and can pass the analyzer to reach the CCD camera. The light 
is absorbed by hemoglobin, yielding an image of the illuminated vessels in negative contrast with a 
resolution of 1 pixel ≈ 1 μm.
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diff usion distance and the heterogeneity index (HI).The MFI (42) is an average fl ow score, 
based on the integer score per quadrant that ranges from no fl ow to continuous fl ow. 
This score is calculated for the diff erent types of vessels, i.e. small (<25 μm), medium (26-
50 μm) and large (51-100 μm). For the FCD calculation (35), the assessor needs to trace 
the path of the moving RBCs within the capillaries (i.e., vessels <10 μm) using a software 
program (Capiscope version 3.7.1.0, KK Technology 1993-2000). A functional capillary is 
defi ned as a capillary that has at least one RBC moving through it during the observation 
period. Dividing the length of the perfused capillaries by the area of interest gives the 
density. In order to calculate the VDI the assessor draws a grid on the computer screen 
fi eld-of-view composed of three equidistant horizontal and three equidistant vertical 
lines. Vessel density is calculated as the number of vessels crossing the lines divided by 
the total length of the lines. Assessment of the HI (29) involves evaluating three to fi ve 
mucosal sites and measuring the MFI in each quadrant, taking the diff erence between 
highest MFI minus the lowest site MFI, and then dividing the number by the mean fl ow 
velocity.
A variety of techniques have been used to assess the microcirculation of critically ill 
patients (43). OPS imaging has been applied in adults in various clinical settings. Little 
is known about the microcirculation in children and infants. A few studies in newborns 
and in infants have used videophotometric microscopy or laser Doppler to evaluate 
blood cell velocity in the nailfold capillaries of the thumb (44-46). OPS imaging of the 
skin has been used in premature and term infants(47-50). These observations show that 
the microcirculation in premature infants can be quantifi ed and RBC velocity can be 
measured.
OUTLINE OF THESIS
The general aims of this thesis were to assess the feasibility of OPS imaging of the buc-
cal microcirculation in children and to investigate the eff ect of treatments used during 
intensive care treatment on microcirculatory hemodynamics. The hypothesis was that 
the microcirculation of critically ill children is altered.
Developmental changes of the microcirculation in young infants are described in 
chapter two. In chapter three I present a report of the OPS technique applied in a child 
with meningococcal sepsis. It shows the feasibility of the technique. Changes of the 
microcirculation in response to treatment with a vasodilator were observed in the fi rst 
24 hours after admission.
Treatments used in the pediatric ICU, such as inhaled nitric oxide (iNO) and extracor-
poreal membrane oxygenation (ECMO) are likely to infl uence microvascular fl ow. iNO is 
used frequently in neonatal and pediatric ICU, especially in neonates with pulmonary 
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hypertension (51). It is administered via the endotracheal tube in order to improve ven-
tilation perfusion mismatch. It is known to be a pulmonary vasodilator. In chapter four 
the results of investigations of the eff ect of iNO on a distal microvascular bed (the buccal 
microcirculation) are presented. Neonates with severe respiratory failure, who were 
treated with ECMO were studied and compared with neonates who were not supported 
by ECMO. The results are shown in chapter fi ve and chapter six. Sepsis is associated with 
severe alterationsin the microcirculation. The time course of these changes is presented 
in chapter seven.
In chapter 8 the key observations from the studies are summarized along with con-
clusions and future perspectives in regards to clinical practice and research into the 
microcirculation. Last, a summary is given in Chapter 9.
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ABSTRACT
Background
Changes in the microcirculation have been recognized to play a crucial role in many 
disease processes. In premature neonates functional capillary density (FCD) decreases 
during the fi rst months of life.
Objective
The aims of this study were to obtain microcirculatory parameters in term neonates and 
older children who did not present with compromised respiration or circulation and to 
determine developmental changes in the microcirculation in young children.
Method
This single-center prospective observational study was performed at a level III university 
children’s hospital. Subjects eligible for inclusion were children up to the age of 3 years 
who did not have any respiratory compromise, circulatory compromise or signs of dehy-
dration. The buccal mucosa of 45 children was assessed, using orthogonal polarization 
imaging (OPS).
Results
We found a signifi cantly higher FCD in neonates younger than 1 week, compared to older 
children. The median FCD was 8.1 cm/cm2 (range 7.3-9.4) for 0- to 7-day-old neonates (n 
= 12), 6.9 cm/cm2 (range 4.7-8.7) for 8- to 28-day-olds (n = 10), 7.3 cm/cm2 (range 6.1-8.8) 
for 1- to 6-month-olds (n = 19) and 6.7 cm/cm2 (range 6.5-9.2) for 3-year-olds (n=4). 
After the fi rst week, there was no signifi cant correlation between age and FCD.
Conclusion
FCD of the buccal mucosa decreases after the fi rst week of life.
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INTRODUCTION
The microcirculation plays a crucial role in the interaction between blood and tissue in 
both physiological and pathophysiological states. Analysis of microvascular blood fl ow 
alterations gives a unique perspective to study disease processes at the microscopic 
level (1). Measurement of tissue perfusion is of great importance in intensive care medi-
cine, mostly because critically ill patients with abnormal tissue perfusion may develop 
multiple organ failure, a complication associated with high morbidity and mortality. 
Macrocirculatory parameters such as blood pressure, heart rate and hemoglobin oxygen 
saturation are rather insensitive markers of tissue perfusion (2).
A variety of techniques has been used to assess the microcirculation of critically ill 
patients. Orthogonal polarization spectral (OPS) imaging is a technique for bedside 
visualization of the microcirculation in which polarized light illuminates the area of in-
terest, is refl ected by the background, and is absorbed by the hemoglobin of the fl owing 
red blood cells in the microcirculation (3). Specifi c optic fi ltration allows the elimina-
tion of light refl ected at the surface of the tissue to produce high contrast refl ected 
light images of the microcirculation. Therefore, in contrast to conventional intravital 
microscopy, there is no need to inject contrast or fl uorescent dyes. This technique is safe, 
non-invasive and allows imaging of mucous membranes and surfaces of solid organs. 
The introduction of OPS imaging to clinical medicine has opened a new fi eld of monitor-
ing of the microcirculation for the investigation of the pathophysiological processes of 
various disease states (4).
The OPS imaging technique has been applied in adults in various clinical settings, 
mainly in sepsis. Little is known about the microcirculation in children and infants. A 
few studies in newborns and in infants have used videophotometric microscopy or laser 
Doppler to evaluate blood cell velocity in the nailfold capillaries of the thumb (5, 6). 
More recently, the group of Genzel-Boroviczeny applied OPS imaging in premature and 
term infants to study the microvascular perfusion of the skin (7, 8). This transdermal ap-
plication of OPS imaging proved useful in premature infants as a non-invasive procedure 
and provided quantitative data of microvascular diameter and red blood cell velocity. 
The functional capillary density in the skin of premature infants decreased signifi cantly 
over the fi rst month of life and correlated with decreases in hemoglobin and incubator 
temperature (7).
We published data on the buccal microcirculation in critically ill neonates (8). Most 
research in adults is done in the sublingual region. This region is diffi  cult or impossible 
to access in younger children because of the size of the probe, and measurements in 
this area are not as well tolerated. In children above the neonatal age the quality of 
transcutaneous measurements is poor because the skin is thicker. The vasculature of 
the skin is also infl uenced by environmental factors such as temperature (9). The skin 
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microcirculation has a specifi c function, namely thermoregulation. This function is not 
shared by other microcirculatory beds, which limits generality. In this study, the buccal 
mucosa was chosen as the site of investigation for several reasons. It shares a similar 
embryonic origin with the splanchnic mucosa, making it a relevant bed to study in 
pathological conditions (10). It is readily accessible and has become an important site 
for microcirculatory studies (2).
The aim of the present study was to determine developmental changes in microcircu-
lation by obtaining microcirculatory parameters in term neonates and children up to the 
age of 3 years who did not present with compromised respiration or circulation. These 
data may serve as reference data for critically ill patients.
METHODS
Setting and Patients
This single-center prospective observational study was performed at the surgical ward 
and the surgical intensive care unit of a level III university children’s hospital. Subjects 
eligible for inclusion were children up to the age of 3 years who did not present with 
any respiratory or circulatory compromise or signs of dehydration. These were mainly 
children with congenital malformations or children admitted for small surgical proce-
dures. The age, gender, weight, underlying diagnosis and medication of all patients 
were recorded in a case report form. Written informed consent was obtained from the 
parents or guardians. Children with fever, signs of infection, congenital heart disease or 
lung disease were excluded.
Technique
The microvascular network was studied with a CYTOSCAN E-II Backfocus type device 
(Cytometrics, Philadelphia, PA) using a 5 x objective. Data were recorded on a Sony 
DSR-20P digital video recorder. Segments of 5 seconds were selected and analyzed 
offl  ine blindly by the fi rst author. Quantifi cation of the images was accomplished us-
ing functional capillary density (FCD) (3). The images created were analyzed with the 
Capiscope software (version 3.7.1.0, KK Technology 1993-2000). For calculation of the 
FCD, the operator traced out the path of the moving red blood cells within the capillar-
ies. Dividing the total length of the perfused capillaries by the area of the fi eld of view 
gives the functional capillary density (cm/cm2).
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Procedure
The microcirculation was assessed in the buccal mucosa. The inside of the cheek is readily 
accessible and intervention was well tolerated in this age group. Moreover, qualitatively 
good images could be obtained from this site.
In case the patient was scheduled for surgery, measurements were performed either 
before or at least one day after the surgery when there were no signs of postoperative 
pain or discomfort. All subjects had fasted for at least 30 minutes before the measure-
ment. First, saliva was gently removed with gauze. The lens of the OPS imaging device 
was covered with a disposable sterile cap and was applied to the buccal mucosa without 
pressure (Figure 1). Images from three diff erent regions were obtained and stored on 
digital videotapes. Segments of 5 seconds were selected and computer captured in AVI 
format. Images had to meet quality criteria, including adequate focus, the absence of sa-
liva and the presence of visible capillaries. Segments that did not meet these criteria were 
discarded. For every child FCD values of the diff erent video segments were averaged. 
Statistical Analysis
The data were analyzed using SPSS 15.0. Pearson’s product moment correlation coeffi  cient 
was calculated to establish the linear relationship between postnatal age and FCD. Patients 
were divided into four age groups: 0-7 days, 7 days- 28 days, 1-6 months and 2-3 years old. 
For comparison between groups the non-parametric Mann-Whitney test was applied.
Results
A total of 45 patients were included (15 female, 30 male). The age ranges within the dif-
ferent groups were 0 - 4 days (median 2 days), 9 - 22 days (median 15 days), 36 - 169 days 
(median 77 days) and 1151 - 1416 days (median 1228 days).  Table1 shows the diagnoses, 
the number of patients and the FCD per group. 
Figure 1. Example of an image (left) and a tracing of the capillaries (right) to determine the FCD.
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The median FCD was 8.1 cm/cm2 (range 7.3-9.4) for 0- to 7-day-old neonates (n = 12), 
6.9 cm/cm2 (range 4.7-8.7) for 8- to 28-day-olds (n = 10), 7.3 cm/cm2 (range 6.1-8.8) for 
1- to 6-month-olds (n = 19), and 6.7 cm/cm2 (range 6.5-9.2) for 3-year-olds (n = 4). (Figure 
2). Figure 3 shows an example of an image.
Table 1: Diagnoses, number of patients and gender per age group
Age group Diagnosis Number Gender
[male/female]
FCD [cm/cm2]
0-7 days Total 12 5/7 8.1 (7.3-9.4) 
Gastro intestinal 9
Urogenital 1
Meningomyelocele 1
Sacrococcygeal teratoma 1
8-28 days Total 10 6/4 6.9 (4.7-8.7)
Gastro intestinal 9
Aplasia cutis 1
1 - 6 monthsmonithmonths Total 20 15/4 7.3 (6.1-8.8)
Gastro intestinal 17
Urogenital 2
Sacrococcygeal teratoma 1
3 years Total 4 4/0 6.7 (6.5-9.2)
Gastrointestinal 3
Subcutaneous abscess 1
FCD is presented as median (range)
Figure 2. Example of measurement technique in one of the patients.
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DISCUSSION
The main fi nding of this study was the FCD of hospitalized infants was highest in the 
fi rst week of life in term infants. This observation is consistent with fi ndings from a study 
in premature and term neonates that employed this technique for measurements of 
the skin (7). Given that these were measurements in the skin, we cannot compare the 
results other than to conclude that postnatal reduction in FCD may be a generalized 
phenomenon. It would seem that developmental changes of the microcirculation in 
early postnatal life are related to adaptation after birth rather than post-conceptional 
age. It is believed that an adult pattern of microvasculature in the skin is reached by the 
age of 3 months (8). An important factor in this is cooling; therefore, it is unclear whether 
the same would apply for other microvascular beds.
The higher FCD in the fi rst week of postnatal life may be related to the notably higher 
cardiac output in the fi rst week (9).  This is likely because the circulatory alterations that 
occur following birth impose an added workload (higher volume load and pressure 
load) on the left ventricle, whereas the pressure load on the right ventricle decreases. 
The added presence of a 2- to 3-fold increase in oxygen consumption at birth due to the 
Figure 3. Boxplot showing functional capillary density (FCD) for diff erent age groups (0-7 days, n = 12), (8-
30 days, n = 10), (1-6 months, n = 19), (3 years, n = 4). FCD for neonates younger than 1 week was higher 
compared to older children. (p < 0.05)
FCD 
(cm/cm2)
0-7 days 8-30 days 1-6months 3 years
4.0
10.0
8.0
6.0
N=12
N=10
N=19
N=4
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work of breathing, increased gastrointestinal function with feeding and especially the 
low temperature environment could be compensated for by higher systemic blood fl ow. 
Moreover, the high levels of fetal hemoglobin reduce the oxygen extraction level (9). 
Over the fi rst few postnatal days resting cardiac output is highest and progressively falls 
afterwards over a 6- to 8-week period (9).
Several other cardiovascular changes found during the initial weeks following birth 
could account for the reduction in FCD observed here.  Wu et al. found an increase in 
skin peripheral vascular resistance during the fi rst 7 days of life and the neonatal period 
that correlated with a decreasing blood fl ow using electrocapacitance plethysmography 
(10). This technique, however, gives information about total blood fl ow and does not 
distinguish between fl ow and vessel density. Beinder et al. suggested that myogenic 
activity in skin arterioles increases with advancing age, a mechanism that might explain 
the reduced functional capillary density observed here (11). Finally, Hb level is closely 
correlated to FCD (7, 12) and has been found to decrease during the 5- to 6-week post-
natal period. Although we did not fi nd a progressive drop in FCD after the age of 1 week, 
decreasing Hb levels may have played a role in the developmental change in FCD during 
the fi rst month of life. In this study, we were not able to correlate Hb levels with FCD.
Microvascular abnormalities can be frequently observed in critically ill patients and 
may play an important role in the pathogenesis of organ dysfunction. Especially due 
to the limitations of monitoring cardiac output and tissue perfusion (13, 14) in young 
children, this non-invasive technique might become an important additive bedside tool 
to the currently used monitoring tools in critically ill neonates and children.
The technique was well tolerated in children under the age of 6 months or over the 
age of 3 years. In children between 6 months and 2 years of age, it was often impos-
sible to perform measurements because these patients were not compliant. Therefore, 
subjects in this age range could not be included in our study because it was too diffi  cult 
to obtain stable images over a long period of time that fulfi lled the quality criteria (15). 
This is because the probe is very sensitive to movements.
To our knowledge, this study presents the fi rst observations of the buccal microcir-
culation in children with a presumably normal cardiovascular system. These data can 
serve as reference data for critically ill children and are relevant for future studies of 
the microcirculation in children. Our study also shows the feasibility of the technique in 
young children. The application in children who are not sedated is limited by the lack 
of compliance in younger age groups. Therefore, we recommend using this technique 
in sedated patients. This technique is a promising bedside tool for future clinical ap-
plication. Further research is needed to investigate older age groups to determine if the 
trend observed in our study is limited to the neonatal period or whether developmental 
changes can be observed throughout childhood.
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CONCLUSION
FCD of the buccal mucosa decreases after the fi rst week of neonatal life. More research is 
needed to investigate the development of vascular resistance and other cardiovascular 
parameters after birth, which might underlie the developmental changes observed in 
the microcirculation of children. 
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ABSTRACT
We report the case of a 3-year-old boy with meningococcal septic shock in whom we 
evaluated the microcirculation in an early phase of the treatment. Meningococcal septic 
shock can lead to multiple organ failure and death. Persistent disturbances in the micro-
circulation, despite recovery of global hemodynamics, may account for such deteriora-
tion.  The microvascular network of the oral mucosa was studied. The functional capillary 
density was 3.2 on admission to the unit and improved to 7.2 after fl uid resuscitation, 
inotropes and vasodilatation. Clinical recovery was good.
This in vivo observation of the microcirculation during the acute resuscitation of a 
child with septic shock suggests that the microcirculation improves by recruitment of 
capillaries.
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INTRODUCTION
Sepsis and septic shock require emergency treatment with antibiotics, appropriate 
fl uid resuscitation and if needed vaso-active drugs. Microvascular failure may persist, 
however, even when macrocirculatory parameters, such as blood pressure, are restored. 
Tissue dysoxia and organ failure may then be the result (1).
The treatment of septic shock aims to restore global hemodynamic function, but 
may not prevent deterioration of the microcirculation. Septic shock causes shunting 
of microcirculatory weak units and disturbs tissue oxygenation (2). Thus, resuscitation 
should target the oxygenation of the microcirculation. In this context, administration of 
vasopressors for restoring blood pressure to improve systemic oxygen delivery may have 
adverse eff ects and even cause more distress because it promotes shunting. Changes in 
the microcirculation cannot be predicted from changes in heart rate, blood pressure 
and pulse oxymetry (3). A new minimally invasive technique, Orthogonal Polarization 
Spectral (OPS) imaging allows imaging of the microcirculation in mucus membranes 
and the surface of solid organs.
In this report we demonstrate how OPS imaging revealed microcirculatory alterations 
in a child with meningococcal septic shock who received vasodilatory therapy. 
CASE
A previously healthy 3-year-old male, who became acutely ill, unresponsive and febrile 
(41.4 °C), was admitted to the Intensive Care Unit after developing petechiae on his 
upper abdominal wall. The diagnosis of Neisseria meningitides type B sepsis was later 
confi rmed. He received a total fl uid amount of 40ml/kg and the maximum dose of do-
butamine was 20 ug/kg.min, norepinephrine 1.0 ug/kg.min, and nitroglycerin 1.0 ug/kg.
METHODS
The microvascular network of the oral mucosa was studied with a CYTOSCAN E-II Back-
focus type device (Cytometrics, Philadelphia, PA). A 5x objective was used. All data were 
visualized on a Philips black and white monitor and recorded on a Sony DSR-20P digital 
video recorder. The measurements were performed in a standardized way. Images from 
three diff erent regions were obtained and stored on digital videotapes. Segments of 5 
seconds were selected and captured in AVI (audio video interleave) format. Segments 
that did not meet quality criteria (4) were discarded. Simultaneously global hemody-
namic parameters were recorded.
Anke Top BW.indd   37 23-11-10   12:01
38 Chapter 3
In accordance with the guidelines of our hospital medical ethical review board, 
informed consent is waived when standard therapy is monitored by non-invasive tech-
niques.
The functional capillary density (FCD) of the vessels was determined by tracing out 
all of the red blood cell perfused capillaries. The total length of the capillaries (vessels, 
smaller than 10 μm) with fl owing cells per fi eld of view was measured using specialized 
software (Capiscope, version 3.7.1.0, KK technology 1993-2000) and expressed in cm/
cm2.
The Microcirculatory fl ow index (MFI) was applied to qualitatively assess perfusion. The 
MFI is based on the determination of the predominant type of fl ow in four quadrants. 
Flow is characterized as absent (0), intermittent (1), sluggish (2) or normal (3). The values 
of the four quadrants are averaged. Statistical analysis of the data was performed using 
SPSS 15.0. The signifi cance of diff erences between scores was tested with the Wilcoxon 
signed rank test.
RESULTS
Table 1 shows vital signs and microcirculatory observations. The fi rst measurement was 
performed after administration of 40ml/kg fl uid and norepinephrine 0.1mcg/kg/min. 
The FCD was 3.2 cm/cm2; the MFI for large, medium and small vessels was respectively 
0.75 / 0.63 / 0.75.  OPS revealed impaired microvascular blood fl ow patterns, especially 
in the capillaries, as well as sludging of red blood cells. A second measurement was 
performed after administration of dobutamine 20mcg/kg/min. The FCD was now 3.5 
cm/cm2; the MFI values were slightly higher, although not signifi cantly, at 0.92 / 0.83 / 
0.83 (large /medium/small vessels, respectively). Between these two measurements the 
heart rate increased from 153 to 173; the blood pressure improved from 71/35 mm Hg 
(mean 49 mm Hg) to 97/33 mm Hg (mean 57 mm Hg). The urine output was unchanged 
(1.2-1.4ml/kg/h). The third measurement, after the administration of 1 μg/kg/min nitro-
glycerin (NTG), yielded an FCD of 6.7 cm/cm2. The blood pressure was 77/42 mm Hg 
(mean 54 mm Hg) and the heart rate had risen to 181. The urine output had increased to 
2.3ml/kg/h. Norepinephrine infusion was discontinued before the fourth measurement; 
the FCD was 6.9 and the MFI increased signifi cantly for all vessel types 2.75 / 2.00 / 2.42 
(large/medium/small).  The blood pressure at that point was 102/46 mm Hg (mean 62 
mm Hg) and the heart rate was 163. The urine output was 2.8ml/kg/h. Amounts of vaso-
active drugs and microcirculatory parameters are shown in fi gure 1.
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DISCUSSION
In this child with septic shock, OPS imaging revealed a compromised microcirculation 
in the fi rst hours of resuscitation, despite apparent improvement in global haemody-
namic parameters after fl uid boluses and start of norepinephrine. OPS imaging enables 
to visualize perfusion on a microcirculatory level in real time. After administration of 
dobutamine the heart rate and blood pressure went up, but microcirculatory perfusion 
did not seem to change. It was only after the administration of vasodilators that the mi-
crocirculatory parameters, in particular vessel density, improved. After discontinuation 
Table 1. Macrocirculatory and microcirculatory parameters
Measurement 1 2 3 4
Hours after admission 0.5 1.5 8 25.5
Heart rate (beats/min) 153 173 181 163
Respiratory rate(breaths/min) 27 37 25 28
Systolic Blood Pressure (mm Hg) 71 97 77 102
Diastolic Blood Pressure (mm Hg) 35 33 42 46
Mean Arterial Pressure (mm Hg) 49 57 54 62
Urine output (ml/kg/hr) 1.2 1.4 2.3 2.8
Serum lactate (mmol/l) 5.0 4.7 4.0 2.3
pH 7.39 7.24 7.41 7.44
FCD (cm/cm2) 3.2 3.5 6.7 6.9
MFI large 0.75 0.92 1.63 2.75
MFI medium 0.63 0.83 1.13 2.00
MFI small 0.75 0.83 1.41 2.42
Figure 1. diagram showing improvement of functional capillary density (FCD) and microcirculatory fl ow 
index (MFI) after introduction of vasodilators. 
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of vasopressors the vessel density did not change and the microvascular fl ow further 
improved. All this suggests that initial vaso-active agents may aff ect the microcircula-
tory shunting. Blood fl ow and recruitment of vessels at microcirculatory level improved 
remarkably after the administration of vasodilators. Data in adults reported by Spronk et 
al (5) support the idea of a role for vasodilators in the improvement of the microcircula-
tion. They showed that nitroglycerin could play a pivotal role in restoration of tissue 
perfusion.  However, because that study was an observational one, it is impossible to 
tell whether pharmacologic eff ects or rather the natural course of the disease led to the 
observed improvement.
Active recruitment of the microcirculation with vasodilators could in fact be a primary 
target.  This would restore the microcirculatory blood fl ow and thus match mitochon-
drial demands. Protecting the microcirculation by opening hypoperfused regions has 
been the key for improved tissue oxygenation in sepsis. Our study proved the feasibility 
of this new technique to visualize microcirculatory fl ow in real time. Further research 
should focus on the eff ect of disease on the microcirculation and to explore eff ects of 
treatments on the microcirculation.
CONCLUSION
OPS imaging is a feasible technique to evaluate the microcirculation and provides new 
insights in the dysfunctional microcirculation in septic shock in children. This technique 
could open the way for guided-therapy in selected patients using the microcirculation 
as a non-invasive biomarker.
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ABSTRACT
Background:
Inhaled NO (iNO) improves outcome in infants diagnosed with persistent pulmonary 
hypertension of the newborn (PPHN), by improving pulmonary blood fl ow and oxygen-
ation. It reduces pulmonary vascular resistance, without fall in systemic blood pressure. 
iNO is also utilized in the treatment of acute hypoxemic respiratory failure in children 
and adults. It is felt to improve regional ventilation perfusion by regional selective pul-
monary vasodilation.
 
Objectives: 
To investigate the eff ect of iNO on the systemic microcirculation. We hypothesized that 
iNO improves the systemic microcirculation. 
Design:
Pilot study
Setting:
Intensive care unit of a level III university children’s hospital. 
Patients:
Consecutive ventilated patients who were treated with iNO (20ppm) were enrolled in 
this study. Eight patients (6 boys, 2 girls) were included; 5 were diagnosed with congeni-
tal diaphragmatic hernia, 1 with PPHN, 1 with ARDS and 1 with bronchiolitis. The median 
age was 0 months (range 0 – 38 months).
Interventions:
iNO administration
Measurements and main results:
The microcirculation was assessed in the buccal mucosa within one hour before and 
within one hour after the start of iNO, using Orthogonal Polarization Spectral imaging. 
The median Functional Capillary Density (FCD) before the iNO was started was 4.0 cm/
cm2 (range1.8 – 5.6) and improved to (4.9 cm/cm2 (range 2.8 – 6.6) (p=0.017)) after the 
start of iNO.
Conclusion:
Inhaled NO improves the systemic microcirculation in children with hypoxemic respira-
tory failure. 
Anke Top BW.indd   44 23-11-10   12:01
Inhaled Nitric Oxide improves systemic microcirculation in infants with hypoxemic respiratory failure 45
INTRODUCTION
Inhaled Nitric oxide (iNO) is frequently used therapy in neonatal and pediatric intensive 
care, especially in neonates with pulmonary hypertension (1). Persistent pulmonary 
hypertension of the newborn (PPHN) describes the state where pulmonary vascular 
resistance fails to fall after birth, resulting in a persistence of fetal circulation. As a 
consequence there is cyanosis due to right-to-left shunting of blood across the fora-
men ovale and the arterial duct (2). PPHN is diagnosed in 0.2 percent of live-born term 
infants. The management consists of identifying and treating the underlying cause 
(e.g. congenital, sepsis, meconium aspiration syndrome), as well as general supportive 
measures, such as sedation and analgesia; maintenance of adequate systemic blood 
pressure; drugs to increase pulmonary vasodilatation and decrease pulmonary vascular 
resistance; maintenance of acid-base balance with supportive mechanical ventilation to 
increase blood and tissue oxygenation, and normalize blood pH (3, 4). High-frequency 
oscillatory ventilation and iNO are frequently used in combination to provide a mode of 
mechanical ventilation that does not impair myocardial function and corrects reversible 
pulmonary hypertension (5).
Nitric oxide (NO) is a major endogenous regulator of vascular tone. INO has been 
investigated as treatment for PPHN in several studies including a number of random-
ized controlled trials (6, 7). It appears to improve outcome in hypoxemic infants and 
reduces the need for ECMO (8). Oxygenation improves in approximately 50% of infants 
receiving iNO (8). It aff ects the pulmonary microcirculation through vasodilation and 
reducing pulmonary vascular resistance, without eff ect on systemic global hemodynam-
ics. It improves ventilation-perfusion matching (9). It decreases right to left shunting 
and improves oxygenation by improving the ratio of pulmonary to systemic vascular 
resistance. INO is thought to replace endogenous NO, which is normally produced by 
endothelial NO synthase.
The classical views of NO as short-lived paracrine agent, which specifi cally acts within 
the lung, are now yielding to a broader paradigm, in which remote delivery of NO is 
recognized. The exact mechanism is still under some debate, but is widely accepted that 
red blood cells (RBCs) and specifi c plasma proteins play a major role in the transport 
and delivery of NO to distant tissues (10-12). Hemoglobin (Hb)-O2 saturation and local 
redox conditions infl uence the local provision of NO bioactivity (13). Thereby coupling 
local oxygen gradients and microcirculatory blood fl ow regulation, by vasodilation or 
vasoconstriction (13).
In this study, we have examined the systemic microcirculation, by OPS imaging of the 
buccal mucosa, in infants with hypoxemic respiratory failure and PPHN. We hypothesized 
that iNO in this patient group would recruit the buccal microcirculation.  
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METHODS
This study took place in the Intensive Care Unit of Erasmus MC Sophia Children’s Hospital 
Rotterdam, which serves as a level III referral center and ECMO facility in the Nether-
lands.  During the study period, eligible consecutive mechanically ventilated patients 
treated with iNO were recruited and enrolled in this study. Patients with an oxygenation 
index (OI) greater than 20 were included. In accordance with the guidelines of the medi-
cal ethical review board of our hospital, informed consent was waived when standard 
therapy is monitored by non-invasive techniques.
All patients underwent echocardiography before the start of iNO. Patients were 
defi ned as having PPHN if the estimated pulmonary pressure (from the tricuspid valve 
regurgitation jet) was more than half the mean systemic arterial pressure. The micro-
circulation of the buccal mucosa was assessed before and after the start of iNO: within 
one hour before (T0) and one hour after (T1). Measurements were performed using our 
standard protocol (14). To evaluate the microcirculation, the CYTOSCAN E-II Backfocus 
type device was applied in order to capture images of the microcirculation. Video seg-
ments of 3 diff erent areas of the buccal mucosa were obtained and the scores were 
averaged (14, 15). 
The exclusion criteria were change of dose of inotropic or vasopressive drugs between 
the two measurements, administration of fl uid bolus between the two measurements, 
congenital heart disease or pre-existing cardiomyopathy and severe blood loss. 
General Management
All patients were mechanically ventilated. All patients received inotopes (dobutamine 
and /or dopamine) and if needed vasopressors (norepinephrine) to maintain a normal 
mean arterial pressure and to improve pulmonary perfusion. Sedation and muscle 
relaxants were given according to our standard protocol (midazolam, morphine and 
vecuronium). Nitric Oxide gas (Nederlandse Technische Gasmaatschappij BV), from a 
1000 ppm cylinder, was introduced in the aff erent limb of the ventilator circuit. The gas 
fl ow of the ventilator was adjusted to yield the target concentration of iNO. NO and 
nitrogen dioxide concentration in the inspired gas were measured by electrochemical 
monitors (Siemens).
MICROCIRCULATORY ANALYSIS
Images were analyzed for vessel density by an investigator (AT), who was blinded for 
the clinical course and order of the images. The Functional Capillary Density (FCD) was 
determined by tracing out all of the red blood cell perfused capillaries. In this way the 
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total length of the capillaries (vessels, smaller than 10 μm) with fl owing cells per fi eld of 
view was measured using specialized software (Capiscope, version 3.7.1.0, KK technol-
ogy 1993-2000) and expressed in cm/cm2 (16).
STATISTICAL ANALYSIS
Statistical analysis of data was performed using SPSS 15.0. Signifi cant diff erence be-
tween scores (before and after iNO) was tested with the Wilcoxon signed rank test. The 
level of signifi cance was set at p < 0.05. Patients who clinically responded to iNO were 
compared with patients who did not respond. A responder was defi ned as a patient who 
showed a greater than 20% improvement in PaO2 (17).
RESULTS
During the study, 11 patients were eligible for inclusion. Three subjects were excluded; 
one because of a cardiac malformation and two patients because the dose of vaso-active 
medication was adjusted between the two measurements. All neonates had PPHN 
diagnosed by a diff erence in pre- and post-ductal oxygen saturation and echocardiog-
raphy. In the two older patients, the echocardiogram showed no signs of pulmonary 
hypertension. Table 1 shows background data and oxygenation and microcirculatory 
values. Only one patient responded clinically to iNO. Despite the treatment with iNO all 
neonatal patients needed treatment with ECMO after a median of 14 hours (range 5-85 
hours). No changes in mechanical ventilation (except in FiO2), vaso-active medication or 
sedation were made between the fi rst and the second measurement. Mean airway pres-
sure remained unchanged between the two measurements. Last, global hemodynamics 
(heart rate, blood pressure) remained stable between the two measurements. The FCD 
increased from 4.0 cm/cm2 (range1.8 – 5.6) to 4.9 cm/cm2 (range 2.8 – 6.6) (p=0.017) 
(Figure 1). There was no diff erence between the responder and non-responders. Despite 
an improvement of FCD, microcirculatory restoration was not complete. Normal values 
vary according to age (18). Reference values for the studied group would lie above 6.0 
cm/cm2 for all patients.
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Figure 1. Box plot illustrating the increase of the FCD between T0 (before) and T1 (after the start of iNO)
FCD 
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Table 1
Patient Gender Age
[days]
Diagnosis  Hematocit
[l/l]
OI 
pre- 
iNO
OI 
post- 
iNO
pO2 
pre- iNO 
[mmHg]
Δ pO2 
[%] 
FCD 
pre- 
iNO 
[cm/
cm2]
FCD 
post- 
iNO 
[cm/
cm2]
1 male 0 CDH 0.43 70 63 28.5 0 4.0 5.2
2 male 0 CDH 0.59 31 30 58.9 0 2.2 4.0
3 male 1 CDH 0.62 55 38 33.0 15 4.1 3.9
4 female 0 CDH 0.41 33 61 60.0 -27 4.0 5.2
5 female 0 CDH 0.45 80 100 22.5 -4 5.6 6.6
6 female 24 MAS 0.26 23 30 86.0 -20 1.8 4.6
7 male 49 bronchiolitis 0.33 23 14 55.5 30 4.5 5.2
8 male 1165 ARDS 0.28 25 20 72.8 16 2.2 2.8
CDH = Congenital diaphragmatic hernia, ARDS = Acute respiratory distress syndrome, MAS = meconium 
aspiration syndrome, OI = oxygenation index.
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DISCUSSION
The main fi nding of this study is that iNO improves the FCD in a distal microvascular bed 
in hypoxemic respiratory failure. There was no eff ect on global hemodynamic param-
eters. 
INO has been shown to reduce pulmonary vascular resistance and improve pulmonary 
hypertension and oxygenation in patients with PPHN, ARDS or after cardiac surgery (19-
21). Several studies have investigated the eff ect of iNO distal to the pulmonary vascular 
bed. It does not aff ect systemic blood pressure (19, 20, 22). 
Two mechanisms could explain the improvement in FCD of the buccal mucosa. Firstly, 
because iNO is a pulmonary vasodilator, it reduces right ventricular afterload and will 
therefore improve myocardial function and cardiac output. A shortcoming of our study 
was that central venous O2 saturation or other surrogate markers of cardiac output were 
not available. However based on the large body of evidence in the adult literature show-
ing that microcirculation is relatively independent of global hemodynamic parameters 
(23, 24), it is unlikely that the improvement in macrocirculation explains the observed in-
crease in microcirculatory perfusion. Secondly, and more likely, the improvement could 
be the result of remote NO bioactivity in the systemic microvasculature and impact on 
its perfusion directly.
Interactions between Hb and NO are very complex. Hb binds NO, forming S-nitroso-
hemoglobin (SNO-Hb), which is currently believed to be major mechanism behind the 
transport and delivery of NO bioactivity. When Hb is oxygenated in the lung, O2 triggers 
an allosteric structure transition of Hb and act as an electron acceptor necessary for SNO 
formation in Hb. Deoxygenation of Hb promotes the decoupling of SNO from Hb, which 
provokes vasodilation (11). Through the infl uence of Hb O2 saturation, redox conditions 
and other allosteric eff ectors on the local NO bioavailability (13), microcirculatory blood 
fl ow is regulated according to metabolic demands. 
Cannon et al (25) showed restoration of vascular resistance and blood fl ow when 
endothelial NO synthesis was blocked. They suggest several mechanisms of vascular 
transport of bioactive NO by RBCs and plasma during iNO. They state that when Hb O2 
saturation and tissue PO2 are very low NO release from RBCs occurs, which is consistent 
with mechanisms proposed in reviews of more recent literature (10, 11, 13). The produc-
tion of SNO-Hb is now considered superior to methemoglobin and heme-iron nitrosyl 
hemoglobin under physiologic conditions (10). 
This mechanism could be a plausible explanation for the observed recruitment of 
the microcirculation. Given the short time span between the two observations, lactate 
or urine output were not monitored and were deemed inaccurate to refl ect change in 
tissue perfusion.
Anke Top BW.indd   49 23-11-10   12:01
50 Chapter 4
In the healthy state and under pathologic conditions, NO maintains microcirculatory 
homeostasis by regulating microvascular tone, leukocyte adhesion, platelet aggrega-
tion, microthrombi formation, and microvascular permeability (26-28). When the micro-
vasculature sustains an insult (e.g. sepsis) the NO molecule becomes vital to maintaining 
microcirculatory patency, integrity and function (29). Nitric oxide is especially attractive 
as a candidate therapy to treat microcirculatory dysfunction in sepsis because in theory 
it could recruit microcirculatory fl ow. In clinical studies of sepsis using OPS imaging, 
the sepsis-induced impairment of sublingual microcirculatory blood fl ow was reversed 
with topical administration of acetylcholine (suggesting that the endothelium was still 
NO-responsive) (30), and intravenous nitroglycerin (a NO donor) (31).
To our knowledge, this is the fi rst observation of the eff ect of iNO on the systemic 
microcirculation in pediatric patients.
CONCLUSION
Inhaled NO improves the systemic microcirculation in children with hypoxemic respira-
tory failure. 
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ABSTRACT
Objectives
 Extracorporeal membrane oxygenation (ECMO) is known to improve cardiorespiratory 
function and outcome in neonates with severe respiratory failure. In this study we tested 
two hypotheses: 1) neonates with severe respiratory failure exhibit alterations of the 
microcirculation, 2) after ECMO therapy these microcirculatory alterations are improved. 
Design
Single-center prospective observational study
Setting
 Intensive care unit of a level III university children’s hospital. 
Patients
Term neonates receiving veno-arterial ECMO. Control patients with and without respira-
tory failure.
Measurements and main results
The microcirculation was assessed in the buccal mucosa, using Orthogonal Polariza-
tion Spectral imaging, before and after ECMO. Functional capillary density was lower 
in patients with severe respiratory failure before ECMO (n=14) compared with control 
patients (n=10) (p<0.01). Functional capillary density had increased signifi cantly after 
ECMO (p<0.01).
Conclusion
Microcirculatory parameters are depressed in neonates with severe respiratory failure 
and improve signifi cantly following ECMO treatment.
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INTRODUCTION
Extracorporeal membrane oxygenation (ECMO) is a cardiopulmonary bypass technique 
used as life support in selected newborns and children with acute reversible cardio 
respiratory failure when conventional management is not successful Worldwide, over 
23,000 neonates have been treated with ECMO for respiratory problems, and the overall 
survival rate was 77% (1).
Monit oring tissue oxygenation is of great importance in intensive care medicine, 
as critically ill patients with abnormal tissue perfusion and oxygenation may develop 
multiple organ failure, a complication associated with high morbidity and mortality. 
So far, it is mainly macrocirculatory parameters such as blood pressure, cardiac output 
and hemoglobin saturation that are routinely measured. Regrettably these parameters 
are rather insensitive markers of tissue oxygenation. Orthogonal Polarization Spectral 
imaging (OPS imaging) allows direct visualization of the microcirculation (2). This non-
invasive technique was recently studied in adults in various clinical settings, mainly 
sepsis, and showed microcirculatory alterations to be associated with poor outcome (3). 
These alterations appeared to be responsive to vasodilators (4). So far little is known 
about the microcirculation in children and infants. Genzel-Boroviczeny et al. studied 
the microvascular perfusion of the skin in preterm and term infants (5,6,). A literature 
search of PubMed yielded no reports on the microcirculation in critically ill newborns 
with severe respiratory failure.
We hypothesize that patients with severe respiratory failure, and therefore compro-
mised cardiovascular function, show microcirculatory alterations and these alterations 
improve after ECMO therapy.
MATERIALS AND METHODS
Setting and Patients
This single-center prospective observational study was performed at an intensive care 
unit of a level III university children’s hospital. Consecutive newborn patients receiving 
veno-arterial ECMO (VA-ECMO) were enrolled between 2004 and 2006. All patients in 
this study had pulmonary hypertension and therefore compromised cardiovascular 
function and were treated with VA-ECMO, according to our unit specifi c policy. To de-
termine potential alterations of the microcirculation in patients with severe respiratory 
failure we compared this group to patients not receiving any form of respiratory or 
circulatory support who served as controls. As these patients soon are transferred it is 
impossible to continue measurements. Additionally the ECMO group was compared to a 
group of patients admitted to the same ICU, with severe respiratory failure, who did not 
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receive ECMO treatment. (Ventilated control group). This group consisted of neonates 
with congenital diaphragmatic hernia. These children were measured several consecu-
tive days after admission. The fi rst measurement was taken as a control for the before 
ECMO measurement and the last measurement was taken to evaluate the changes over 
time without ECMO treatment. Children with congenital heart disease were excluded.
In accordance with the guidelines of the medical ethical review board of our hospi-
tal, informed consent is waived when standard therapy is monitored by non-invasive 
techniques. Demographic data and clinical parameters before and after ECMO, like the 
vasopressor score (7) are shown in Table1. Patients in the study group had severe car-
diorespiratory failure and hypoxemia despite adequate conventional treatments such 
as mechanical ventilation, sedation, muscle paralysis, vaso-active drugs, and nitric oxide 
inhalation.  All patients met the established entry criteria for ECMO (8) and received 
ECMO treatment, according to a standard protocol. ECMO fl ow was weaned on the 
guidance of changes in arterial pO2 and signs of pulmonary hypertension, until a fl ow 
rate of 50ml/min was reached. ECMO was then discontinued by clamping the external 
circuit. Decannulation followed when the patient’s clinical condition was satisfactory. If 
a patient’s condition did not improve within the fi rst couple of days on ECMO we started 
vasodilators to accelerate the weaning process.
Technique
OPS imaging (2), was used to visualize the microvascular network of the buccal mu-
cosa. The measurements were done with a CYTOSCAN E-II Backfocus type device (Cy-
tometrics, Philadelphia, PA) using the x 5 objective. All data were recorded on a Sony 
DSR-20P digital video recorder. Segments of 5 seconds were selected and analyzed 
off -line blindly by the fi rst author. Quantifi cations of the images were accomplished as 
described previously (2). The total length of the capillaries (vessels, smaller than 10 μm) 
with fl owing cells per fi eld of view was measured using specialized software (Capiscope, 
version 3.7.1.0, KK technology 1993-2000) and expressed as functional capillary density 
(FCD (cm/cm2)). 
Procedure 
The microcirculation was assessed within 24 hours before start and within 48 hours after 
discontinuation of ECMO. In the study period control subjects were measured once.
Before the measurements, saliva was gently removed with gauze. The lens of the OPS 
imaging device was covered with a disposable sterile cap and was applied to the buccal 
mucosa without pressure. This was best accomplished by placing a hand on the patient 
or on the bed for stabilization. The tip of the probe is inserted into the mouth and placed 
on the buccal surface. When an image appears the probe is retracted slightly prior to 
gently placing it on the surface of the mucosa in a way that the probe just makes contact 
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with the mucosa. Images from 3 diff erent regions were obtained and stored on digital 
videotapes. Segments of 5 seconds were selected and captured in AVI format. Images 
had to meet quality criteria, such as adequate focus, the absence of saliva and the pres-
ence of visible capillaries. Segments that did not meet these criteria were discarded. For 
every measurement point FCD of the diff erent video segments was averaged. If only one 
segment was good enough, this score was taken.
Statistical Analysis
The data were analyzed using SPSS 14.0. For comparison of two groups (e.g. patients 
before or after ECMO therapy and controls) the Mann-Whitney test was applied. Sig-
nifi cance of diff erence between scores (before and after ECMO) was tested with the 
Wilcoxon signed rank test. The level of signifi cance was set at p < 0.05.
Results
In the study period 41 patients were eligible. In 16 patients one of the measurements 
could not be done for logistic reasons. Two patients died immediately after ECMO, due 
to therapy withdrawal. Approximately 20% of all the captured video segments was 
judged as unfi t for reliable analysis. In 9 cases one of the measurements was unfi t in 
terms of image quality and these were rejected.
Video segments from 14 patients with respiratory failure, 9 boys and 5 girls, were eli-
gible for analysis. The underlying diseases were congenital diaphragmatic hernia (n =7), 
meconium aspiration syndrome (n =5), and persistent pulmonary hypertension of the 
neonate (n = 2). Table 1 shows relevant clinical parameters. The median duration of the 
ECMO therapy was 141 (range 60 to 253) hours. Median time between the measure-
ment and start of ECMO was 1.5 (range 1 to 24) hours and between discontinuation and 
the fi nal measurement 4.5 (range 1 to 47) hours. Before ECMO 4 patients were treated 
with magnesium sulphate and none received Sildenafi l, after ECMO 8 patients received 
magnesium sulphate and 3 were given Sildenafi l in a dose of 5-10mg/kg/day.
The non-ventilated control group consisted of 5 boys and 5 girls. Diagnoses of these 
patients were esophageal atresia (n=4, including 2 patients with also anal atresia), me-
conium plug syndrome (n=2), duodenal atresia (n=1), meningomyelocele (n=1), ompha-
locele (n=1), sacrococcygeal teratoma (n=1). The ventilated control group consisted of 
10 patients diagnosed with congenital diaphragmatic hernia, 5 boys and 5 girls. In one 
of the patients only one measurement could be done, so for the second measurement 
n=9. During the fi rst measurement none of these patients were treated with magnesium 
sulphate and none received Sildenafi l, During the second measurement one of these 
patients received magnesium sulphate and one was given Sildenafi l in a dose of 8 mg/
kg/day.
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Microcirculatory parameters
Functional capillary density (FCD) was signifi cantly lower in patients with severe respi-
ratory failure before ECMO therapy (n=14) compared to control patients (n=10) with 
a median of 4.5 (range 2.4 to 6.2) vs. 8.1 (range 6.6 to 9.4) respectively, (p<0.01). FCD 
increased signifi cantly after ECMO therapy, median 6.8 (range 4.4 to 9.0), (p<0.01) but 
remained lower than the FCD of the control group (p=0.05). There was no diff erence in 
FCD between the ventilated control group and the ECMO group, before ECMO (p=0.59). 
FCD in the ventilated group was 5.1 (range 1.8 to 8.0). In the ventilated group the FCD did 
not improve (FCD 3.4 (range 1.2 to 5.1) (p=0.18), in contrast to the ECMO group. (Figure 1)
Table 1. Clinical parameters of patients before and after ECMO therapy and of controls
ECMO group Control groups
 Before ECMO  
n = 14
Median 
(Range)
After ECMO  
n = 14
Median 
(Range)
Non ventilated
n = 10
Median 
(Range)
Ventilated, fi rst 
measurement  
n = 10
Median 
(Range)
Ventilated, last 
measurement  
n = 9
Median 
(Range)
Age [days] 0 (0-12) 6 (3-18) 1 (0-4) 0 (0-5) 7 (1-12)
Gestational age 
[weeks] 39 (36-42) 40 (38-42) 38 (37-39) 38 (37-39)
Birth weight [kg] 3.5 (1.9-5.1) 3.3 (2.5-4.1) 3.6 (1.8-5.4) 3.0 (1.8-5.4)
Mean Airway 
Pressure [cmH2O] 17 (14-27) 15 (10-19)a 13 (8-17)a 10 (8-14)a
Ventilation Mode 
[HFO vs. CMV] 10 vs. 4 3 vs. 11 7 vs. 3 2 vs. 7 
Nitric Oxide (n) 9 1 5 2
Oxygenation 
Index 31 (5-86) 6 (2-15)a 7 (3-25)a 4 (2-7)a
Heart Rate [/min] 179 (120-209) 143 (121-158)b 139 (100-163)b 148 (113-193) 141 (113-172)b
Mean Blood 
Pressure [mmHg] 46 (29-77) 48 (36-64) 47 (32-65) 44 (32-60) 51 (42-60)
Pulse pressure 
[mmHg] 25 (11-40) 26 (18-35) 24 (16-31) 19 (12-36) 25 (15-28)
Vasopressor score 28 (0-180) 11 (0-30)b 65 (0-80) 10 (0-35)b
Midazolam [mcg/
kg/hr] 100 (0-200) 250 (0-400)b 100 (0-200) 200 (0-300)
Morphine [mcg/
kg/hr] 18 (10-40) 20 (5-400) 13 (0-23) 10 (0-20)
Paralysis 
[number of 
patients] 7 0 0 2
Hb [mmol/l] 9.2 (8.2-12.5) 7.0 (6.0-9.2)a 10,5 (6,7-13,6) 9.8 (6.2-11.0) 7.9 (6.1-10.8)
compared with before ECMO  a p≤0.01, b p<0.05
Abbreviations
HFO High Frequency Oscillation, CMV Conventional Mandatory Ventilation
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DISCUSSION
This is the fi rst study to show that patients with severe respiratory failure have depressed 
microcirculation. In this study we focus on a specifi c group of patients who receive ECMO 
treatment after meeting criteria for ECMO treatment (8). The circulation and oxygenation 
of these patients are disturbed (1) indicating a compromised cardiovascular function. 
Refl ecting this condition, these patients’ microcirculatory parameters were signifi cantly 
reduced before ECMO. Although macrocirculatory parameters like blood pressure were 
adequate, perfusion at the microcirculatory level was diminished. Studies in adults have 
shown that macrocirculatory parameters can not adequately refl ect the perfusion at 
tissue level and that the circulation at microcirculatory level has a prognostic value (3,4). 
The functional capillary density improved signifi cantly following ECMO, as hypoth-
esized, in parallel to improved clinical condition of patients. Improvement was achieved 
even though the Hb level, which has been described to promote a higher FCD (6), was 
Figure 1. Box plot of Functional Capillary Density of newborns with severe respiratory failure. Before 
extracorporeal membrane oxygenation (ECMO) the functional capillary density (FCD) is signifi cantly lower 
than the FCD of  non ventilated control patients (p<0.01) and it is not diff erent from the FCD of ventilated 
control patients at the same stage of the admission. After ECMO the FCD signifi cantly improves (p<0.01). 
No improvement in FCD is seen in the ventilated control group after the same time course.
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signifi cantly lower after ECMO. FCD is highest in the fi rst week after birth (9). Therefore, 
the improvement found, is most likely not to be ascribed to normal developmental 
changes, but rather to the clinical therapy of which ECMO was an important component. 
Although the eff ect of other factors like vasodilators can not be ruled out, this study 
describes changes in the microcirculation in a group of patients who received ECMO 
treatment following our standard of care. Because the vasopressor score at the second 
measurement, as well as the time interval between the measurements is comparable 
for the ECMO and the ventilated control group and the mean airway pressure is lower in 
the control group, we consider the clinical improvement in at the second measurement 
comparable. Therefore, this will not explain the diff erence in development of the FCD.
ECMO therapy gives time to restore normal pulmonary oxygenation to neonates 
with severe respiratory failure who do not respond to maximal conventional therapy. 
If lung rest does not achieve spontaneous clinical improvement, these patients receive 
phosphodiesterase inhibitors per our unit policy. Therefore, after ECMO many patients 
were given vasodilators, which may have contributed to the improvement seen in mi-
crocirculatory parameters.
The improvement in FCD after ECMO correlates well with an improvement in clinical 
condition. After ECMO patients needed less cardiac support and vasopressors, which 
may also have benefi ted the microcirculation. As the study sample was small, we were 
not able to perform a multi-variate analysis. Therefore, further research is needed done 
in larger samples to determine the infl uence of diff erent variables. 
CONCLUSION
Microcirculatory parameters are depressed in term neonates with severe respiratory 
failure and improve signifi cantly following ECMO treatment.
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ABSTRACT
Purpose
Extracorporeal membrane oxygenation (ECMO) is known to improve cardiorespira-
tory function and outcome in neonates with severe respiratory failure. We tested the 
hypothesis that veno-arterial ECMO (VA-ECMO) therapy improves the microcirculation 
in neonates with severe respiratory failure.
Methods
This single-center prospective observational study took place in an intensive care unit 
of a level III university children’s hospital. Twenty-one term neonates, who received VA-
ECMO treatment, were studied. The microcirculation was assessed in the buccal mucosa, 
using Orthogonal Polarization Spectral imaging, within 24 hours before (T1) and during 
the fi rst 24 hours of ECMO treatment (T2). Data were compared to data of a ventilated 
(N=7) control group that was measured with the same time interval and a single mea-
surement of a non-ventilated control group (N=10).
Results
The initiation of ECMO provides cardiac output and therefore has an impact on the mac-
rocirculation, refl ected by a signifi cantly decreased vasopressor score. The microcircula-
tion remained preserved in the ECMO treated group (functional capillary density (FCD) 
did not change; median 4.5 (range 2.4-7.7) at T1 and 4.3 (range 2.8-7.4) at T2 (p=0.47)), 
while it deteriorated in those patients solely treated with mechanical ventilation. The 
FCD in this group decreased from median 5.0 (range 1.8-7.2) at T1 to median 2.4 (range 
1.4-4.2) at T2, (p=0.03). 
Conclusion
VA-ECMO preserves the microcirculation in neonates with severe respiratory failure.
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INTRODUCTION
Extracorporeal membrane oxygenation (ECMO) is a cardiopulmonary bypass technique 
used as life support in selected newborns and children with acute reversible cardiorespi-
ratory failure when conventional management is not successful. Worldwide, over 24,000 
neonates have been treated with ECMO for respiratory problems (1).
ECMO therapy gives time to restore normal pulmonary oxygenation in neonates with 
severe respiratory failure who do not respond to maximal conventional therapy and 
is regarded as a bridge to recovery. The institution of veno-arterial ECMO (VA-ECMO) 
partly takes over oxygenation and carbon dioxide removal and thereby allows ventilator 
settings to be reduced and restores circulation.
The institution of an ECMO circuit in neonates results in an expansion of the circulat-
ing volume by approximately factor 3. In VA-ECMO the heart is bypassed and fl ow in the 
systemic circulation is generated mostly by the ECMO pump, producing non-pulsatile 
fl ow. Especially during high ECMO fl ow rate (120-200 ml/kg/min) this results in distur-
bance of the physiologic blood fl ow, which can be represented by a fl attening of the 
arterial pulse waves on invasive blood pressure monitoring.
In neonatal patients with severe respiratory failure, who meet the criteria for ECMO 
treatment (2), the circulation and oxygenation are severely compromised. Refl ecting this 
condition, these patients’ microcirculatory parameters are signifi cantly reduced before 
ECMO (3). At the time when the patient no longer needs ECMO, the microcirculatory 
parameters are improved, correlating well with an improvement in clinical condition (3). 
Direct eff ects of artifi cial, non-pulsatile ECMO fl ow on the microcirculation are still not 
completely understood.
Based on clinical observations and the instant decrease of need for vasoactive medi-
cation after the start of ECMO therapy, we hypothesize, that microcirculatory alterations 
observed in neonates with severe respiratory failure improve with the initiation of ECMO 
therapy. 
MATERIALS AND METHODS
Patients 
Neonatal patients (aged ≤ 28 days) admitted to our ICU and treated with VA-ECMO were 
enrolled in this study. Patients were treated with ECMO, according to our unit specifi c 
policy. Patients suff ering from congenital heart disease were excluded.
In accordance with the guidelines of the medical ethical review board of our hospital, 
informed consent was waived when standard therapy is monitored by non-invasive 
techniques. Patients in the study group had severe cardiorespiratory failure and hy-
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poxemia despite adequate conventional treatments such as mechanical ventilation, 
sedation, muscle paralysis, vasoactive drugs, and nitric oxide inhalation.  All patients 
met the established entry criteria for ECMO (2). Initially the aimed ECMO fl ow rate was 
150-200 ml/kg/min and after 24 hours weaning of the fl ow was started under guidance 
of changes in arterial pO2 and signs of pulmonary hypertension.
In addition to the microvascular measurement, patient’s demographic and clinical 
parameters, such as gender, birth weight, gestational age, postnatal age, diagnosis, 
ECMO fl ow, heart rate, blood pressure, mean arterial blood pressure, body temperature, 
administered medication, hemoglobin and hematocrit levels were recorded. Data were 
compared to data of control subjects, who were not ventilated, and to a group of patients 
with severe respiratory failure, who did not receive ECMO treatment. The non-ventilated 
group consisted of patients who were admitted to the same unit and did not receive 
any form of respiratory or circulatory support. This group served as a control group in 
a previous study (3).  As these patients soon were transferred they were only measured 
once. In the ventilated control group patients were measured several consecutive days 
after admission. The fi rst two measurements on consecutive days were taken to serve as 
control for T1 and T2 and to evaluate the changes without ECMO treatment. 
Procedure
The microcirculation was assessed within 24 hours before start of ECMO (T1) and within 
24 hours after start of ECMO (T2). OPS imaging (4) was used to visualize the microvascu-
lar network of the buccal mucosa. The measurements were done with a CYTOSCAN E-II 
Backfocus type device (Cytometrics, Philadelphia, PA), using the 5x objective.
Before the measurements, saliva was gently removed with gauze. The lens of the OPS 
imaging device was covered with a disposable sterile cap and was applied to the buccal 
mucosa without pressure, as described before (3). Images from 3 diff erent regions were 
obtained and stored on digital videotapes, using a Sony DSR-20P digital video recorder. 
Segments of 5 seconds were selected and captured in AVI (audio video interleave) 
format. Video segments that did not meet quality criteria (3) were discarded. For every 
measurement, the FCD of the diff erent video segments was averaged. If only one seg-
ment met the quality criteria, this score was taken.
Microcirculatory Analysis
Quantifi cation of the images was performed as described previously (3, 4). To investigate 
vessel density the images were analyzed with the Capiscope software program (version 
3.7.1.0, KK Technology 1993-2000). For the Functional Capillary Density (FCD) calcula-
tion, the analyst is required to trace out the path of the moving red blood cells within the 
capillaries (vessels, smaller than 10 μm). A functional capillary is defi ned as a capillary 
that has at least one red blood cell moving trough it, during the observation period. 
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Dividing the length of the perfused capillaries by the area gives the functional capillary 
density value expressed in cm/cm2
Statistical Analysis
The data were analyzed using SPSS 15.0. Signifi cance of diff erence between scores (T1 
vs.T2) was tested using the Wilcoxon signed rank test. For comparison of two groups, the 
Mann-Whitney test was applied. The level of signifi cance was set at p < 0.05. 
RESULTS
During the study period, 31 VA-ECMO patients were eligible for inclusion. Twenty-one 
patients were included according to the protocol. Four patients were missed for inclu-
sion due to logistic reasons (researcher was not contacted in time or no investigator 
or camera available). Six patients were excluded because their video segments did not 
meet the quality criteria (3). The excluded group did not diff er from the included patient 
group for gestational age, postnatal age, diagnosis, duration of ECMO treatment or 
mortality. The diagnoses of the ECMO patients were congenital diaphragmatic hernia 
(CDH) (n=10), meconium aspiration syndrome (n=5), persistent pulmonary hyperten-
sion of the neonate (n=5) and congenital cystic adenomatoid malformation (CCAM) 
of the lung (n=1). The group existed of 9 female and 12 male patients, with a median 
gestational age of 39.6 (range 34.4-42.5) weeks and a median birth weight of 3.1 (range 
2.3-5.1) kg. In the non-ventilated group (n=10), the median age was 1 day (0-4), the 
median gestational age 40 weeks (38-42), and the median birth weight 3.3 kg (2.5-4.1). 
The ventilated control group consisted of neonates with CDH (n=7). Their median age 
was 1 day (0-6), their median gestational age 38.1 weeks (38-39.3), and their median 
birth weight 3.0 kg (3.0-3.8).
After the start of ECMO, macrocirculatory parameters were stable, while the dose 
of vasoactive drugs could be signifi cantly reduced (Table1). The FCD did not change 
signifi cantly. The FCD before ECMO (T1) was 4.5 (range 2.4-7.7) and after the start of 
ECMO therapy (T2) 4.3 (range 2.8-7.7), (p = 0.47). In the ECMO group, the FCD on T1 
was not statistically signifi cantly diff erent from the FCD of ventilated control patients 
(p=0.81). In this group the median FCD decreased from 5.0 (range 1.8-7.2) to 2.4 (range 
1.4-4.2) (p = 0.03). On T2, the FCD was signifi cantly lower in the ventilated control group 
compared to the ECMO group (p=0.002). The FCD in the non-ventilated control group 
was signifi cantly higher than in the other groups. (Figure 1)
All patients in the control group survived. Three patients in the ECMO treated group 
(CDH n=2, CCAM n=1) did not survive, due to recurrent and therapy resistant pulmonary 
hypertension.
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DISCUSSION
The main fi nding of our study was that there was no change in microcirculatory pa-
rameters after the start of VA-ECMO therapy. Nevertheless, it seems to preserve the 
microcirculation, while deterioration was observed in patients with severe respiratory 
failure, who did not receive ECMO treatment. Despite the fact that patients in the ECMO 
group were more severely ill, in comparison with the patients in the ventilated control 
group (OI in ECMO group signifi cantly higher), ECMO succeeded to better microcircula-
tory support compared to solely conservative treatment with mechanical ventilation 
and pharmacologic support, where there was a deterioration. ECMO resulted in stabi-
lizing macro- and micro- circulation, and a reduced vasopressor score, whereas in the 
ventilated control group, the macrocirculation was stabilized but more vasopressor was 
given, resulting in a deterioration of the microcirculation.
Thus, ECMO seems to prevent a further deterioration of microcirculatory perfusion. An 
important confounding factor is the change in vasoactive medication between T1 and 
T2, because vasopressors have been suggested to have a negative eff ect on perfusion 
of the microcirculation, despite increase of cardiac index (5, 6). Although the change in 
Table 1. Macro- and microcirculatory values
T1 ECMO T2 ECMO T1 Ventilated 
Controls
T2 Ventilated 
Controls
Age [days] 1 (0-12) 1 (0-12) a 1 (0-6) 1 (0-7) a
Time interval to or from start 
ECMO fl ow [hours]
2 (0.5-24) 2 (0.5-24) - -
Heart Rate [/min] 180 (120-220) 150 (106-198) 138 (113-191) d 129 (110-160)
Mean Blood Pressure [mmHg] 49 (29-77) 49 (35-86) 44 (32-60) 52 (41-63)
Pulse pressure [mmHg] 19 (10-40) 10 (0-33) a 25 (12-36) 24 (15-32) c
Vasopressor score 40 (0-140) 10 (0-108) a 15 (0-75) 19 (0-66)
Dopamine [μ/kg/min] 10 (0-20) 0 (0-20) 10 (0-21) 16 (0-21) c
Dobutamine [μ/kg/min] 10 (0-20) 5 (0-20) 10 (0-20) 5 (0-20)
Norepinephrine [μ/kg/min] 0.1 (0-1.0) 0 (0-0.9) 0 (0-0.4) 0 (0-0.3)
Inhaled Nitric Oxide [ppm] 20 (0-40) 0 (0-0) a 0 (0-19) 0 (0-20) d
Hemoglobin [mmol/l] 9.2 (6.9-12.6) 8.7 (6.7-12.0) 8.7 (7.4-11.0) 8.5 (7.8-10.8)
Hematocrit [l/l] 0.45 (0.32-0.62) 0.41 (0.31-0.56) 0.43 (0.38-0.53) 0.40 (0.34-0.53)
Temperature [degrees Celsius] 37.4 (34,4-38.6) 36.9 (35.9-38.4) 37.3 (36.7-38.4) 36.8 (36.5-37.3)
ECMO fl ow [ml/kg/min] - 140 (110-210) - -
FCD [cm/cm2] 4.5 (2.4-7.7) 4.3(2.8-7.4) 5.0 (1.8-7.2) 2.4 (1.4-4.2) b,c
Data are presented as median and range. Comparison of T1 and T2 within groups was performed with the 
Wilcoxon signed ranks test. For comparison between groups the Mann-Whitney test was applied.
Compared toT1 within group a p≤0.01, b p<0.05
Compared ECMO group  c p≤0.01, d p<0.05
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vasopressor score between T1 and T2 in the control group is not statistically signifi cant, 
there is a tendency towards more vasopressive medication and less vasodilators on T2, 
which could possibly explain the reduction of FCD in this group. Another factor could 
be cardiac output (CO). All patients had pulmonary hypertension. This can compromise 
the pulmonary venous return and preload of the left ventricle, and therefore infl uence 
global hemodynamics. No measures of CO were available in this study, so this can not 
be verifi ed.
Although ECMO provides CO and bypasses the lung, it does not restore microcircula-
tory tissue perfusion instantly. This is in contrast to observations in adults showing an 
improvement of microvascular fl ow secondary to improvement of cardiac output (7). 
This observation suggests a lack of correlation between CO and microcirculatory perfu-
sion. This is consistent with a large quantity of evidence in the adult literature showing 
that microcirculation is relatively independent of global hemodynamic parameters (8). 
Optimal macrocirculation, however, is the obvious prerequisite for adequate microcir-
culatory perfusion. It is unclear why there was no improvement of the microcirculation, 
while the macrocirculation was restored. During cardiopulmonary bypass (CPB) in adults, 
Figure 1. Box plot of the functional capillary density (FCD) of newborns with severe respiratory failure who 
were treated with extracorporeal membrane oxygenation (ECMO) (n=21), before (T1 ECMO) and within 
the fi rst 24 hours after the start of ECMO (T2 ECMO), ventilated controls (n=7) and non-ventilated controls 
(n=10).
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microcirculatory alterations have been described before (9-12). We found one report on 
microcirculatory alterations during CPB in neonates where OPS was used, which shows 
a reduction in vessel density during CPB (13).
In previous observations our group found that after treatment with ECMO, at a time 
when the patient was recovering and no longer needed ECMO (within 48 hours after dis-
continuation), the microcirculatory parameters had improved (3). Based on the instant 
restoration of the macrocirculation, it was expected that microcirculatory alterations 
observed in neonates with severe respiratory failure, would improve with the initiation 
of ECMO therapy.
Factors that could prevent further recruitment of the microcirculation at this point 
could be the primary disease process, which seems to cause a further deterioration of 
tissue perfusion, or direct eff ects of EMCO fl ow. The initiation of ECMO causes infl amma-
tion, triggering of the catecholamine system resulting in vasoconstriction and formation 
of microscopic thromboemboli or gaseous microemboli (14). There is an infl ammatory 
reaction aggravated by the exposure of blood to the artifi cial components of the ex-
tracorporeal circuit and by the surgery necessary for cannulation (15). To which degree 
ECMO contributes to the infl ammatory response is unknown. It is suggested that the 
infl ammatory reaction in response to extracorporeal circuits is remarkably similar to 
the reaction that occurs during severe infl ammatory response syndrome (SIRS) (14). 
A marked infl ammatory reaction is recognized from early after the start of ECMO and 
frequently persists for several days (16-19). ECMO related SIRS is thought to occur due 
to contact with the surface of the artifi cial circuit (20). Possible other ECMO related 
mechanisms are reperfusion injury on initiation of ECMO and, in case of VA-ECMO, non-
pulsatile fl ow generated by the ECMO pump (17). Additionally, severe respiratory failure 
and subsequent hypoxemia for which ECMO is required, the banked blood used for 
circuit priming and, possibly, the surgical procedure needed for cannulation could be 
factors that aggravate SIRS (16, 19).
Flow disturbances are well known in sepsis and SIRS (21, 22). Infl ammation leads to a 
variety of alterations on the microvascular level, of which the most important are micro-
vascular thrombosis, shunting of blood, increased capillary permeability and an altered 
oxygen metabolism (14). These factors could explain the persistently reduced capillary 
density. Although blood of ECMO recipients is constantly heparinized and special fi lters 
are used, the possibility of gaseous microemboli or microscopic thromboemboli forma-
tion cannot be excluded. By occluding the microcirculation these microemboli could 
therefore be of infl uence on the observed low FCD.
Disturbance of physiologic fl ow also triggers the catecholamine system leading to 
vasoconstriction and altered tissue perfusion (14). Although the mechanism behind 
is not completely understood, Agati et al (23-25) reported that in cardiac patients on 
CPB non-pulsatile fl ow seemed to aff ect the microcirculation and organ perfusion in a 
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more negative way than pulsatile fl ow did. The benefi cial eff ects of pulsatile VA-ECMO 
systems are still debated (26-28). More research is needed to explore the eff ect of above-
mentioned factors on the microcirculation. Folllow-up investigations of the microcircu-
lation are necessary and comparison of survivors and non-survivors within the group 
that received ECMO treatment. In this way, the prognostic value of microcirculatory 
parameters can be determined.
Limitations
There were some limitations to our study. First, the lack of cardiac output (CO) measure-
ments limits the possibility to relate microvasular observations to global hemodynam-
ics. Changes in CO could possibly play a role in the decrease of FCD between T1 and T2 
in the control group. In children, it is not routine to measure mixed venous saturation 
and cardiac output. A prerequisite for adequate CO monitoring is a tool that is accurate, 
is easy to use, and has an acceptable risk-benefi t profi le. These three factors have con-
stituted the major hurdle to bedside pediatric cardiac output measurement to date (29). 
The reliability of echocardiography evaluation of cardiac output in children is debatable 
because even in the hands of experienced operators the inter- and intra-individual 
variation is large (30), which is why we did not use this form of assessment. In addi-
tion, especially in neonates intra-and extracardiac shunts complicate the use of these 
measurements. Second, this study is observational and not randomized controlled, 
which skews outcome data. If children in the control group had disposed progressive 
respiratory and/or circulatory failure, they would have received ECMO treatment. From 
an ethical perspective, randomization for this type of treatments is unacceptable.
CONCLUSION 
The initiation of ECMO preserves the microcirculation in neonates with severe respira-
tory failure.
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ABSTRACT
Objectives
To investigate the time course and predictive value of microvascular alterations in chil-
dren with severe sepsis.
Design
Single-center prospective observational study.
Setting
Intensive Care unit of a level III university children’s hospital. 
Patients
Patients with septic shock, requiring the administration of fl uid and vasopressor agents 
and /or inotropes after the correction of hypovolemia, who were intubated and venti-
lated, were included.
Interventions
None.
Measurements and main results
The microcirculation was assessed in the buccal mucosa, using Orthogonal Polarization 
Spectral imaging, within 24 hours after admission and subsequent measurements were 
performed every 24 hours for three days. The measurements were discontinued when 
the patient was extubated.
There were no signifi cant diff erences in the Functional Capillary Density (FCD) or Mi-
crovascular Flow Index (MFI) for all vessel types between survivors and non-survivors 
on day 1. In the survival group the FCD increased signifi cantly between day 1 and day 2 
from 1.7 cm/cm2 (0.8-3.4) to 4.3 cm/cm2 (2.1-6.9) (p=0.001). FCD values in non-survivors 
did not change (day 1: 3.2 cm/cm2 (0.8-3.8), day 2: 1.9 cm/cm2 (1.0-2.1)). The median 
FCD on days 2 and 3 were signifi cantly lower in non-survivors (1.9 cm/cm2 (1.0-2.1) vs. 
4.3 cm/cm2 (2.1-6.9) (p=0.009) and 1.8 cm/cm2 (1.0-2.0) vs. 4.7 cm/cm2 (2.1-8.6) (p=0.01) 
respectively).  The MFI for all vessel types improved in survivors and did not change in 
non-survivors. Diff erences in MFI values between survivors and non-survivors were not 
signifi cant.
Conclusion
Persistent microcirculatory alterations can be prognostic for survival in children with 
septic shock. 
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INTRODUCTION
Sepsis and septic shock requires emergency treatment with antibiotics, appropriate 
fl uid resuscitation and, if needed, vaso-active drugs (1). Despite major improvements 
in the management of patients with severe sepsis, patients can develop multiple organ 
failure (MOF) and will subsequently die.
Microvascular alterations are frequent in patients with sepsis (2). Indirect evidence 
indicates that improving the microcirculation may prevent or ameliorate sepsis-induced 
organ failure (3). This state can be very critical as there is a great risk for developing 
multiple organ dysfunction syndrome (MODS) (4).
With the advances of pediatric intensive care therapy, overall mortality in children has 
been reduced to approximately 10% (1, 5). Unlike adults, children who die of shock usu-
ally do so because of decreased cardiac output with high or normal systemic vascular 
resistance (6). Mortality rates improve with an early, aggressive fl uid resuscitation as well 
as vasopressor and inotropic support if signs of shock persist (7, 8).
Clinical parameters that are routinely used for the evaluation of treatment of children 
with sepsis are mainly focused on the macrocirculatory part of the cardiovascular 
system. However, restoration of the systemic hemodynamics does not eliminate the 
possibility that there is still deterioration of the microcirculation and organ dysfunction 
and MOF can still frequently occur (9, 10). In septic shock microcirculatory weak units 
become shunted and tissue oxygenation is disturbed (11). Thus, an adequate resuscita-
tion procedure should target the oxygenation of the microcirculation. Changes in the 
microcirculation cannot be predicted from changes in heart rate, blood pressure and 
pulse oxymetry (2, 12).
Orthogonal Polarization Spectral (OPS) imaging allows imaging of mucus membranes 
and the surface of solid organs and can be applied at the bedside to investigate the 
human microvasculature (13, 14).
Major microvascular blood fl ow alterations in patients with severe sepsis are described 
in adults (2). These alterations included a decreased vascular density and were more 
severe in non-survivors than in survivors but were not aff ected by the global hemody-
namic state or vasopressor agents. More and more, alterations of the microcirculation 
are assumed to play a crucial role in sepsis (3, 15). Left uncorrected, these processes will 
lead to cellular dysfunction followed by organ failure and death (3, 10, 15-17). Weidlich 
et al. described decreased vessel density of the skin in neonates in the 5 days prior to 
the onset of sepsis (18). To our knowledge, no reports on the microcirculation in children 
during sepsis are available in literature.
In this study, we performed daily measurements using the OPS technique in patients 
with septic shock to investigate the time course of microvascular alterations. 
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METHODS
This study took place in the Intensive Care Unit of Erasmus MC Sophia Children’s Hos-
pital Rotterdam. In accordance with the guidelines of the medical ethical review board 
of our hospital, informed consent is waived when standard therapy is monitored by 
non-invasive techniques. Patients with septic shock, as defi ned by the American Col-
lege of Critical Care Medicine (19), requiring the administration of fl uid and vasopressor 
agents and /or inotropes after the correction of hypovolemia, who were intubated and 
ventilated, were included. Subjects were measured within 24 hours after admission and 
subsequent measurements were performed every 24 hours for three days. The measure-
ments were discontinued when the patient was extubated. Demographic data (sex, 
age, weight) and the Pediatric Risk of Mortality (PRISM) score (20) were recorded for all 
subjects. During each measurement global hemodynamic parameters vaso-active drug 
dose expressed as vasopressor score (21) were recorded as well. Exclusion criteria: treat-
ment with Extra Corporal Membrane Oxygenation (ECMO), congenital heart disease or 
pre-existing cardiomyopathy and severe blood loss. 
General Management
All patients had an arterial and central venous catheter. Treatment for septic shock 
was standardized, including fl uid resuscitation and inotropes (dobutamine and /or 
dopamine) and vasopressors (norepinephrine and, if needed, epinephrine as well) to 
maintain a normal mean arterial pressure, according to the guidelines for management 
of sepsis (22). All patients were mechanically ventilated. Sedation was given following a 
unit specifi c protocol (with midazolam and morphine) and was increased according to 
individual needs.
Imaging 
To evaluate the microcirculation, the CYTOSCAN E-II Backfocus type device (Cytometrics, 
Philadelphia USA) was applied to acquire images of the microcirculation. The buccal mu-
cosa was studied and video segments were obtained in a standardized way, as described 
previously (23).
Microcirculatory analysis
Images were analyzed for vessel density by the fi rst author and fl ow by the third author, 
who were blinded for the clinical course and order of the images. The functional capillary 
density (FCD) was determined by tracing out all of the red blood cell-perfused capillar-
ies. In this way the total length of the capillaries (vessels, smaller than 10 μm) with fl ow-
ing cells per fi eld of view was measured using specialized software (Capiscope, version 
3.7.1.0, KK technology 1993-2000) and expressed in cm/cm2 (13). Semiquantitative fl ow 
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scoring was performed using the Microcirculatory Flow Index (MFI), a method published 
by Boerma et al. (24). This score is based on the determination of the predominant type 
of fl ow in 4 quadrants of the screen. Flow is characterized as absent (0), intermittent (1), 
sluggish (2) or normal (3). The values of the 4 quadrants are averaged.
Statistical Analysis
Statistical analysis of the data was performed using SPSS 15.0. For comparison of two 
groups (survivors and non-survivors) the Mann-Whitney test was applied. Survivors 
were defi ned as patients who were alive at day 28 after admission. The signifi cance of 
diff erences between scores (day 1, day 2 and day 3) was tested with the Wilcoxon signed 
rank test. The predictive value of change in FCD values (ΔFCD) on survival was calculated 
using a receiver operator characteristic (ROC) curve and the area under the curve (AUC) 
was computed. The level of signifi cance was set at p < 0.05. Data are presented as the 
median (and the range).
RESULTS
Twenty-one consecutive patients were studied (Figure 1). Four patients died, one of 
whom died within 48 hours, before a second measurement could be done. Seventeen 
patients survived. Two patients were only measured once; 1 patient because she was ex-
tubated within 24 hours, and, therefore, the measurements were discontinued, whereas 
1 patient could not be measured on day 2 due to logistical reasons. The 3 patients 
Figure 1. Flow diagram of patients included in the study
Eligible patients
N=21
Survivors
N=17
Non-survivors
N=4
Included
N=15
Measured on D1, D2 and D3
N=10
Measured on D1 and D2 
N=5
Included
N=3
Only 1 measurement
N=2, excluded
Only 1 measurement
N=1, excluded
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that missed follow-up measurements (2 survivors and 1 non-survivor) were excluded. 
These patients were not diff erent from the included patients in terms of microcircula-
tory values or clinical parameters. Background data are shown in Table 1. Five patients 
could not be measured on the third day due to logistical reasons (e.g., no investigator 
available, technical problems with camera).  All non-survivors died due to MOF. Global 
hemodynamic parameters are shown in Table 2.
Table 1. Back ground data
Patient Sex Age [months] Weight [kg] Cause of sepsis PRISM score Survival
1 Male 45 18.0 Meningococcal sepsis 40 Yes
2 Male 26 12.7 Bowel perforation 20 Yes
3 Male 67 4.2 St. Aureus sepsis 30 Yes
4 Female 178 60 Neutropenia 31 No
5 Male 8 9 Urosepsis 29 Yes
6 Male 18 10 Meningococcal sepsis 31 Yes
7 Male 0 2.8 Bowel obstruction 19 Yes
8 Male 6 22 Bowel obstruction 17 Yes
9 Male 107 40 Neutropenia 13 Yes
10 Male 31 13
Neutropenia, Immune 
defi ciency
18 No
11 Male 146 33 Pneumonia ARDS 19 Yes
12 Female 1 1.3 Necrotizing Enterocolitis 40 Yes
13 Female 89 25 Meningococcal sepsis 20 Yes
14 Female 184 45 Bowel perforation 26 Yes
15 Female 3 2.5 Necrotizing Enterocolitis 18 No
16 Female 190 58.0 Toxic Shock Syndrome 3 Yes
17 Male 38 12.6 Sepsis-meningitis 30 Yes
18 Female 189 55.0 Bowel perforation 20 Yes
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Table 2. Macrocirculatory parameters and catecholamine doses
Survivors Non-survivors
Day 1 
(n=15)
2 
(n=15)
3 
(n=10)
1
(n=3)
2
(n=3)
3
(n=3)
Heart rate
[beats/min]
169
(121-210)
150
(124-194)
142 *
(101-175)
169
(168-173)
167
(163-170)
155
(129-180)
Mean arterial 
blood pressure
[mm Hg]
60
(27-88)
65
(39-89)
66
(43-86)
54
(32-66)
66
(42-72)
74
(65-74)
Diastolic blood 
pressure
[mm Hg]
45
(21-74)
52
(32-73)
54
(32-76)
52
(32-73)
45
(32-55)
56
(48-60)
Systolic blood 
pressure
[mm Hg]
85
(30-136)
99
(56-145)
100
(57-141)
99
(56-145)
112
(59-125)
95
(92-111)
Dopamine
[mcg/kg/min]
0
(0-27)
0
(0-27)
0
(0-27)
0
(0-5)
0
(0-5)
0
(0-5)
Dobutamine
[mcg/kg/min]
5
(0-20)
13
(0-21)
5 !
(0-21)
20
(0-21)
20
(0-20)
10
(0-20)
Norepinephrine
[mcg/kg/min]
0.1
(0-1.0)
0.1
(0-1.0)
0 *!
(0-1.0)
0.4
(0.4-1.2)
0.5
(0.3-1.4)
0.4
(0.3-1.4)
Epinephrine
[mcg/kg/min]
0
(0-0.7)
0
(0-0.9)
0
(0-0.2)
0
(0-0.1)
0
(0-0.4)
0
(0-0.4)
Fluid bolus 
crystalloids
[ml/kg]
0
0-36
0
0-44
0 *
0-20
10
0-32
9
0-10
0
0-0
Fluid bolus 
colloids
[ml/kg]
12 
0-340
0 *
0-56
0 *
0-10
12
0-48
13
0-20
25
0-42
Vasopressor Score 10
(0-52)
15
(0-52)
8 *
(0-47)
24
(14-43)
25
(18-38)
18
(14-38)
Body temperature
[°Celsius]
38.1
(34.5-39.8)
37.5
(36.0-40.7)
37.5
(36.4-38.5
36.7
(36.1-36.7)
37.1
(36.7-37.7)
37.1
(35.6-39.3)
Lactate [mmol/l] 3.3
(1.0-11.6)
2.4 *
(0.8-19)
11
(1.4-15)
9.2
(1.8-15)
14.2
(1.9-14.4)
Urine output
[ml/kg/h]
1.5
(0-4.0)
2.8
(0-7.3)
2.9 *
(1.5-5.9)
0.3
(0.3-2.3)
0.5 †
(0.5-1.0)
0.7
(0.1-5.8)
Hemoglobin
[mmol/l]
6.0
(3.1-8.1)
6.6
(5.8-12.3)
6.3
(5.2-8.1)
6.6
(6.0-8.1)
5.4
(5.1-7.4)
6.0
(5.8-7.9)
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Microcirculatory parameters
Microcirculatory parameters are shown in Table 3. All patients who had at least two 
measurements were included. Changes in microvascular scores were analyzed. There 
were no signifi cant diff erences in the FCD or the MFI for all vessel types between survi-
vors and non-survivors on day 1. In the survival group, the FCD increased signifi cantly 
between day 1 and day 2 from 1.7 cm/cm2 (0.8-3.4) to 4.3 cm/cm2 (2.1-6.9) (p=0.001).
The FCD in non-survivors did not change (day 1: 3.2 cm/cm2 (0.8-3.8) and day 2: 1.9 cm/
cm2 (1.0-2.1)) (Figure 2). In the survivors the ΔFCD was 2,3 (-0.4-4.4). Non-survivors had a 
lower ΔFCD ( -1.3 (-1.7-0.2)) (p=0.01). The Microvascular Flow Index (MFI) improved in all 
vessel types in survivors (day 1: small 2.00 (0.33-2.75), medium 1.92 (0.08-2.5), large 2.13 
(0.67-3.00), day 2: small 2.63 (2.06-3.00) (p=0.001) medium 2.62 (1.66-3.00) (p=0.004), 
large 2.83 (2.00-3.00) (p=0.01). MFI values in non-survivors did not change (day 1: small 
2.75 (1.00-2.88), medium 2.38 (0.75-3.00), large 2.75 (1.63-3.00), day 2: small 2.17 (2.00-
2.33), medium 2.00 (1.25-2.33), large 2.50 (1.92-3.00).  
The median FCD values on days 2 and 3 were signifi cantly lower in non-survivors, 1.9 
cm/cm2 (1.0-2.1) vs. 4.3 cm/cm2 (2.1-6.9) (p=0.009) and 1.8 cm/cm2 (1.0-2.0) vs. 4.7 cm/
cm2 (2.1-8.6) (p=0.01), respectively. Diff erences in the MFI between survivors and non-
survivors were not signifi cant.
Survivors Non-survivors
Day 1 
(n=15)
2 
(n=15)
3 
(n=10)
1
(n=3)
2
(n=3)
3
(n=3)
pH 7.32
(7.20-7.47)
7.39 *
(7.21-7.51)
7.42 *
(7.30-7.49)
7.19 †
(7.14-7.24)
7.31†
(7.26-7.34)
7.35
(7.11-7.55)
pCO2
[kPa]
4.4
(3.4-7.4)
4.7
(4.1-8.6)
5.5
(4.9-7.3)
7.2
(3.4-7.5)
5.6
(2.8-6.4)
5.5
(4.2-6.3)
Base Excess
[mmol/l]
-9
(-16 - -3)
-3
(-8- 7)
2
(-3 - 9)
-8
(-20- -6)
-6
(-14 - -3)
-3
(-14 - 6)
Global hemodynamic parameters of survivors and non-survivors and dose of vaso-active medication. For 
the age range, the normal mean blood pressure ranges from 35-85 mmHg with diastolic blood pressure 
from 25-75 mmHg and systolic blood pressure from 50-140 mmHg. For comparison of survivors and non-
survivors the Mann-Whitney test was applied. The signifi cance of diff erences between day 1, day 2 and 
day 3, within groups, was tested with the Wilcoxon signed rank test. Global hemodynamics and the dose 
of vaso-active medication were not signifi cantly diff erent between survivors and non-survivors.
Data are presented as median and range
* Signifi cantly diff erent from day 1 (p<0.05)
! Signifi cantly diff erent from day 2 (p<0.05)
† Signifi cantly diff erent from survivors on the same day (p<0.05)
Vasopressor score= ([dopamine x 1] + [dobutamine x 1] + [epinephrine x 100] + [norepinephrine x 100] + 
[phenylephrine x 100]) (21)
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Table 3. Microvascular fl ow index on day 1-3
Survivors Non-survivors
Day 1 
(n=15)
2 
(n=15)
3 
(n=10)
1
(n=3)
2
(n=3)
3
(n=3)
MFI large 2.13
(0.67-3.00)
2.83 *
(2.00-3.00)
2.71 *
(2.13-3.00)
2.75
(1.63-3.00)
2.50
(1.92-3.00)
2.45
(2.40-2.50)
MFI medium
1.92
(0.08-2.5)
2.62 *
(1.66-3.00)
2.44
(1.25-3.00)
2.38
(0.75-3.00)
2.00
(1.25-2.33)
1.58
(0.86-2.30)
MFI small 2.00
(0.33-2.75)
2.63 *
(2.06-3.00)
2.54
(1.27-3.00)
2.75
(1.00-2.88)
2.17
(2.00-2.33)
1.62
(0.63-2.60)
Data are presented as median and range
* Signifi cantly diff erent from day 1 (p<0.05)
† Signifi cantly diff erent from survivors on the same day (p<0.05)
MFI Microvascular Flow Index
Figure 2. The Functional Capillary Density (FCD) improves in survivors (day 1:1.7 cm/cm2 (0.8-3.4) and day 
2: 4.3 cm/cm2 (2.1-6.9) (p=0.001)). The FCD in non-survivors did not change (day 1: 3.2 cm/cm2 (0.8-3.8) 
and day 2: 1.9 cm/cm2 (1.0-2.1)). The median FCD on day 2 was lower in non-survivors, (1.9 cm/cm2 (1.0-
2.1) vs. 4.3 cm/cm2 (2.1-6.9) (p=0.009))
Survivors
0
1
2
3
4
5
6
7
8
Day 1 Day 2
FCD
[cm/cm2]
Non-survivors
0
1
2
3
4
5
6
7
8
Day 1 Day 2
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A ROC curve showed that the ΔFCD is predictive for survival. A ΔFCD of 0.7, the best 
cut-off  had a sensitivity of 87% and a specifi city of 100%. The area under the curve 
was 0.956 (95% CI 0.853-1.058). For PRISM the area under the curve was 0.59 (95%CI 
0.209-0.969), which is statistically signifi cantly less sensitive and specifi c than the ΔFCD 
measured by the ROC curve (Figure 3).
Figure 3. Receiver operator characteristic curve for the change in Functional Capillary Density (ΔFCD) 
within the fi rst 2days of septic shock in children. The best cut-off  is 0.7 Area under the curve (AUC) for 
ΔFCD =0.956 (95% CI 0.853-1.058). The ROC curve for PRISM shows a low sensitivity and specifi city. It has 
an area under the curve of 0.59 (95%CI 0.209-0.969) and is signifi cantly less sensitive and specifi c than 
ΔFCD measured by the ROC curve.
DISCUSSION
The main fi nding of our study is that in children with septic shock, despite normalization 
of the systemic hemodynamic variables, persistence of microcirculatory alterations is 
associated with a worse outcome. Although microcirculatory parameters were similar in 
survivors and non-survivors on the fi rst day, our study demonstrates recruitment of the 
microcirculation in the survivors of septic shock, but not in the non-survivors. Despite 
a restored macrocirculation, which was similar in all groups, 3 of the 18 patients did not 
survive and the improvement of the microcirculation appeared to be a distinctive fea-
ture. Capillary density increased over time in the survivors but not in the non-survivors. 
Due to the small number of patients in the non-survival group, it is diffi  cult to generalize 
based on our observation. Our fi nding is in accordance with observations in adults by 
Sakr et al. (17) and by Trzeciak et al. (25, 26). They found that microcirculatory alterations 
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were best correlated with the occurrence and severity of MOF and that persistent altera-
tions in microvascular perfusion at later than 24 hours after the onset of shock were a 
good predictor of ICU mortality.
Circulatory shock is defi ned as a failure of the cardiovascular system to maintain 
eff ective tissue perfusion, causing cellular dysfunction and acute organ system failure 
if not promptly restored. Although it is the macrocirculation that distributes blood 
fl ow globally throughout the body, the microcirculation is a critical component of the 
cardiovascular system that is necessary for blood fl ow to individual tissues. It has been 
previously described in adults that indices of microcirculatory blood fl ow, in patients 
with septic shock, could serve as early indicators of tissue hypoperfusion and herald the 
onset of multi-organ failure and death (15, 25, 27).
Distinctive diff erences were found for vessel density. There were diff erences in devel-
opment in MFI over the time as well, although these were less pronounced. There was no 
improvement in the MFI of the non-survival group, which might be because the initial 
MFI was high, so, therefore, it is diffi  cult to observe improvement. This might also be the 
result of the small sample size.
Microcirculatory perfusion is regulated by an intricate interplay of neuroendocrine, 
paracrine, and mechano-sensory pathways (10). This regulated system can be further 
compromised by the following: decreased deformability of red blood cells and the 
consequent increased viscosity (28); increased percentage of activated neutrophils, with 
decreased deformability and increased aggregability due to upregulation of adhesion 
molecules (29); activation of the clotting cascade with fi brin deposition and the forma-
tion of microthrombi, leading to dysfunction of vascular autoregulatory mechanisms 
(30); or secondary enhanced perfusion of large arteriovenous shunts (31). These pro-
cesses result in tissue dysoxia, either from impaired microcirculatory oxygen delivery or 
from mitochondrial dysfunction (32). New larger studies are needed to confi rm the role 
of vessel density and to explore the infl uence of the above-mentioned factors.
Other indexes of impaired tissue perfusion also improved more rapidly in survivors. 
Urine output improved in survivors, while it did not increase in non-survivors. Arterial 
lactate concentrations decreased more rapidly in survivors. The lack of restoration of the 
microcirculation may explain these diff erences. Based on our fi ndings, the prognostic 
markers for survival in children with septic shock should also include variables like lac-
tate and urine output, however these are microcirculation dependent variables and FCD 
can be considered as a more direct visible hemodynamic marker.
After the fi rst day, microvascular perfusion discriminated survivors and patients dying 
of MOF, while global hemodynamic measurements and the use of vaso-active drugs 
did not signifi cantly diff er. Previous studies reported that microcirculatory alterations 
can be observed in patients with septic shock (2, 15, 33). An important fi nding was 
that improvement of microcirculatory alterations, but not the global hemodynamic 
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or oxygenation variables, was related to survival. This relationship is illustrated by the 
area under the ROC curve (Figure 3). In accordance with observations in adults, global 
hemodynamic variables in our study were similar in survivors and non-survivors on days 
2 and 3, despite the signifi cantly altered tissue perfusion in non-survivors. In addition, 
it has been shown that improvement in microcirculatory perfusion in the initial hours 
following early goal directed therapy results in an improved sequential organ failure as-
sessment (SOFA) score 24 hours later (34). The microcirculation is thus emphasized as an 
important player in the pathophysiology of shock and MOF, and therefore mortality (17). 
Microvascular recruitment can therefore be a possible target for resuscitation in patients 
with septic shock (11, 15, 25). Although the use of vasopressors (e.g. norepinephrine) 
was not signifi cantly diff erent between survivors and non-survivors in our study, the use 
of vasopressors under certain circumstances can infl uence microcirculatory variables 
(34).
There are several limitations and technical diffi  culties involved in performing the 
measurements that make them, in their present form, unsuitable for routine clinical use. 
Further studies are necessary to defi ne potentially benefi cial interventions, and studies 
that assess the microcirculation, like OPS and Sidestream Dark Field (SDF) Imaging, may 
be helpful in evaluating their eff ects on the microcirculation.
Limitations
There were some limitations to our study. First, in children, it is not routine to measure 
mixed venous saturation and cardiac output, as placement of Swan-Ganz catheter in 
children has never reached the application as in adults with septic shock. A prerequi-
site for adequate CO monitoring is a tool that is accurate, is easy to use, and has an 
acceptable risk-benefi t profi le. These three factors have constituted the major hurdle 
to bedside pediatric cardiac output measurement to date (35). Because we do not have 
continuous oxygen saturation measurement catheters for small children and because of 
the small size central venous line (CVL), we restrict the blood sampling of the line and we 
do not know the mixed venous saturation. In children, the reliability of echocardiogra-
phy evaluation of cardiac output is debatable because even in the hands of experienced 
operators the inter- and intra-individual variation is large (36), which is why we did 
not use this form of assessment. Therefore, we have limited information about global 
hemodynamics. Thus, monitoring the microcirculation could be a valuable addition in 
the monitoring of critically ill children, given its non-invasive nature.
Second, the sublingual mucosa, which shares a similar embryonic origin with the 
digestive mucosa, may not refl ect other microcirculatory beds (37). Nevertheless, as this 
study and others have shown, it is a sensitive location capable of predicting morbidity 
and mortality in advance of macroscopic hemodynamic parameters.
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And fi nally, the possibility of correlating the observed values with lactate is limited by 
the fact that lactate was not measured in a signifi cant number of the patients at the time 
of the measurement because we were dependent on the laboratory determinations 
taken on clinical indication by the treating team. Therefore, especially when high lactate 
levels were not anticipated, this issue was not investigated.
CONCLUSION
Persistent microcirculatory alterations can be prognostic for survival in children with 
septic shock. Imaging of the microcirculation may therefore open the way for guided-
therapy. It can be valuable in addition to the limited techniques for monitoring hemody-
namics in children and in selected patients using the microcirculation as a non-invasive 
biomarker. Recruitment of microcirculation may become an important therapeutic 
target in treatment of septic shock in the pediatric age group.
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INTRODUCTION
Circulatory shock is an important problem in critical illness; it is a major cause of morbid-
ity and mortality (1, 2). Shock is defi ned as the failure of the circulation to meet the 
metabolic demands of the tissues. Although it is one of the most seen and extensively 
studied problems in the intensive care unit, it remains an elusive process to monitor. The 
optimal method of hemodynamic monitoring to guide resuscitation and management 
of the critically ill patient is still controversial. The importance of tissue perfusion is well 
recognized, but current standard monitoring techniques often fail to elucidate local 
alterations in regional tissue perfusion. Global hemodynamic parameters are routinely 
used as primary endpoints in the treatment of shock (3). To date there are no tools, how-
ever, that could be used to routinely monitor tissue perfusion or tissue oxygenation at 
the bedside. Monitoring the microcirculation could narrow the gap between the infor-
mation obtained by currently used methods and the information that is really needed.
Over the last decade, there has been considerable research into the role of the mi-
crocirculation in the pathophysiology of multiple organ failure during critical illness. 
The network of blood vessels that make-up the functional microcirculatory network 
provides the anatomical basis for supplying oxygen and nutrients to all cells in the body. 
It is the primary prerequisite for cell life. The microcirculation continuously adapts to the 
needs of the tissues by being responsive to tissue metabolic signals that, ultimately, will 
control vascular tone, and therefore regional blood fl ow.
Microvascular perfusion is dependent on suffi  cient cardiac output and systemic blood 
pressure. However, their relationship is very complex, determined by the underlying 
illness and possibly by treatments. Observations from laboratory preparations as well 
as bedside observations in patients have shown that, at a microvascular level, there is 
autoregulation (4, 5). That is, microvascular vessel density and fl ow, vessel heterogene-
ity, arteriolar-to-venous shunting are dissociated from systemic eff ects.
Most of the clinical research into the microcirculation has been carried out in adults 
with sepsis. The concept that dysfunction of the microcirculation contributes to the 
pathophysiology of sepsis is now widely accepted (6, 7). In fact, this has led to the idea 
that microcirculatory dysfunction can be regarded as the ‘motor’ that drives the devel-
opment of multiple organ failure during sepsis (6). Very little work has been done in 
children. In this chapter, the current literature on direct observation of the microcircula-
tion in pediatric patients will be reviewed. Taking the literature fi ndings together with 
the results of the studies presented in this thesis, perspectives for future developments 
in monitoring the microcirculation will be discussed.
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OBSERVING THE MICROCIRCULATION IN THE PEDIATRIC PATIENT
The improved successor of OPS imaging (8), sidestream dark fi eld (SDF) imaging is based 
on the dark fi eld illumination technique introduced by Sherman et al. (9). Transilluminat-
ing the tissue is not needed in this technique. Instead, SDF imaging uses a stroboscopic 
light-emitting, diode ring-based imaging device illuminating from the side of the fi eld 
of view to avoid surface refl ection, thereby providing better image quality of the micro-
circulation than does OPS imaging (10).
To date, eight studies have been published on the use of OPS or SDF imaging in 
children (Table 1). A few studies in newborns and infants have used videophotometric 
microscopy or laser Doppler to evaluate red blood cell (RBC) velocity in the nailfold cap-
illaries of the thumb (11-13). The latter technique is not feasible for routine bedside use. 
OPS imaging of the skin of the upper arm has been used in premature and term infants 
(14-17). The microcirculation as well as RBC velocity could be quantifi ed in premature 
infants. The most frequently used site for assessment in older children is the buccal 
mucosa.
 Table 1. Pediatric studies of the microcirculation using OPS or SDF imaging
Author [ref] Year Age range n SDF/OPS Site Outcome
Genzel-
Boroviczeny et 
al. (14)
2002 Preterm, 
1-5 days
28 OPS Skin Feasibility study: RBC velocity 
increases from day 1-5 in premature 
neonates and correlates with 
decrease in hemoglobin
Genzel-
Boroviczeny et 
al. (15)
2004 Preterm, 
19-39 days
13 OPS Skin FCD improves 2 hours and 24 hours 
after blood transfusion
Kroth et al. (16) 2008 Preterm, 
0-30 days
25 OPS Skin FCD decreases signifi cantly over the 
fi rst month of life
Top et al. (18) 2009 Term, 0-18 
days
14 OPS Buccal 
mucosa
FCD is reduced in neonates with 
severe respiratory failure and 
improves with veno-arterial 
extracorporeal membrane 
oxygenation 
Weidlich et al. 
(19)
2009 Preterm, 
0-30 days
10 OPS Skin FCD decreases 1 day before clinical 
signs of infection appear
Hiedl et al. (17) 2010 Preterm, 
3-8 days
25 SDF Patients with persistent ductus 
arteriosus have reduced FCD, which 
improves after treatment
Top et al. (20) 2010 0-3 years 45 OPS Buccal 
mucosa
FCD of the buccal mucosa decreases
after the fi rst week of life
Top et al. (21) 2010 0-15 years 21 OPS Buccal 
mucosa
Persistence of depressed FCD is 
associated with a worse outcome in 
children with septic shock
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MICROCIRCULATION IN DISEASE AND THE EFFECTS OF TREATMENT
Microcirculatory abnormalities have been described in four diff erent conditions or 
states. First, our clinical research group showed with OPS that microcirculatory values 
in critically ill neonates with severe respiratory failure were depressed and could be 
infl uenced by certain treatments (18), (chapters 4-6). Second, we have demonstrated 
alterations of the microcirculation in infants and children with sepsis (21), (chapters 
3 and 7). In addition, others have reported alterations in the microcirculation of pre-
mature neonates with infection (19). Third, in premature neonates with patent ductus 
arteriosus (PDA), the functional capillary density (FCD) of the skin is reduced compared 
with neonates without PDA (17). The mechanism behind this is not clear. However, the 
left-to-right shunting through the PDA reduces the cardiac output (due to blood being 
shunted to the pulmonary circulation) may provide an explanation, seeing that there 
was no diff erence anymore after closure of the PDA (17). Lastly, Genzel-Boroviczeny 
et al. observed a direct eff ect of RBC transfusion on the microcirculation in premature 
infants, i.e. an increase of the FCD (15). RBC transfusion is a common intervention used 
to improve oxygen delivery to the tissues. 
MICROCIRCULATION IN THE CRITICALLY ILL NEONATE WITH SEVERE 
RESPIRATORY FAILURE
We found depressed microcirculatory values in neonatal patients with severe respiratory 
failure with pulmonary hypertension. These patients had lower microvascular values 
compared with children without respiratory failure or signs of pulmonary hypertension. 
The alterations proved sensitive to diff erent treatments (chapters 4-6). The question 
is whether these observations lie at the basis of the respiratory disease process or are 
merely epi-phenomena in the bigger picture of failure of the pediatric (micro-) circula-
tion to adapt to post natal life.
The functional morphology of the cardiovascular system changes markedly at birth 
due to dramatic alterations in blood fl ow patterns. The fetal circulation is characterized 
by reduced perfusion of the lungs and intra- and extra-cardiac shunts between the 
pulmonary and systemic circulations. It develops and undergoes changes in the fi rst 
few years of life but then rapidly transitions into an adult circulation under normal 
circumstances (Chapter 1). 
Developmental changes in the structure of the microcirculation occur in the fi rst few 
weeks of life in healthy neonates and children (16, 20). The FCD of the buccal mucosa 
decreases after the fi rst week. After birth, there is a 2- to 3-fold increase in oxygen con-
sumption because of increased work of breathing, and increased gastrointestinal func-
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tion with feeding. Furthermore, high levels of fetal hemoglobin at this time of life reduce 
the level of oxygen extraction (22). These factors, taken together, can be compensated 
for by higher systemic and microcirculatory blood fl ow. The higher FCD in the fi rst week 
of postnatal life may be related to higher cardiac output (22) and autoregulation of 
regional blood fl ow may have a role in this process (23).
Failure to produce normal physiologic changes of circulation after birth is not com-
pletely understood. Pathophysiologic mechanisms are inherent to certain birth defects 
(e.g. congenital diaphragmatic hernia (CDH)) and may cause persistent pulmonary hy-
pertension of the neonate (PPHN) (24). These mechanisms diff er from those underlying 
other causes of PPHN (e.g. meconium aspiration or infection).
Many of the patients with severe respiratory failure that we studied were diagnosed 
with CDH. In this birth defect, normal postnatal physiologic changes of circulation fail to 
occur. There is a high degree of lung hypoplasia and pulmonary vascular abnormalities 
(24). Newborns with CDH show a decreased pulmonary expression of inducible nitric ox-
ide synthase (iNOS), which suggests a potential role in the pathogenesis of pulmonary 
hypertension (25). Nitric oxide (NO) is a key factor in the maintenance of the low normal 
pulmonary vascular resistance (PVR) in children as well as in adults (26). In health, NO 
maintains microcirculatory homeostasis (27-30), while causing injury under pathologi-
cal conditions. Thus, the microvascular system of the lung plays an important role in the 
pathophysiology of CDH.
We found that neonates with CDH with severe respiratory failure had depressed 
microvascular perfusion values (chapters 4-6). It is unclear if these alterations correlate 
with alterations in the lung microvasculature. More research is needed to understand 
the full hemodynamic pattern in this patient group. For example, global hemodynamic 
monitoring by echocardiography and cardiac output monitoring should be combined 
with observations of the microcirculation, thus providing an integrative method of 
monitoring the functional state of the cardiovascular system. In addition, comparisons 
between patients with and without CDH could confi rm the possibility of CDH being an 
intrinsic disease of the microcirculation.
PROGNOSTIC VALUE OF THE MICROCIRCULATION
OPS and SDF imaging have been used in adults in various clinical settings. The mea-
surements derived from observation of the microcirculation in sepsis proved to have 
prognostic value (31-33). This prognostic value has also been shown for other disease 
states (34, 35). Altered microcirculatory parameters in adults with septic shock that do 
not resolve after 24 hours of admission are associated with poor outcome (32). Abnormal 
microcirculatory values also correlate with other measures of patient severity of illness 
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during sepsis, such as sequential organ failure assessment (SOFA) scores (33). Sublingual 
microcirculatory parameters were also found to be impaired in patients who develop 
nosocomial infections after major abdominal surgery (35). Lastly, De Backer et al. found 
that the degree of microvascular derangement in adults with cardiogenic shock was 
refl ected in their survival (34).
With regard to children, we found that persistent alterations of the microcirculation 
were associated with poor outcome in septic shock (21), (chapter 7). Persistent altera-
tions proved to have a stronger predictive value for mortality than the pediatric risk of 
mortality (PRISM) model. In premature neonates, reduction of FCD of the skin can be the 
fi rst sign of infection (19). Such alteration might be predictive of infection even before 
clinical suspicion arises. The observations in pediatric patients with septic shock and the 
prognostic value of change in microvascular alterations over time, are consistent with 
those in adults (32). Sepsis is now well recognized as having a major impact on the mi-
crocirculation. Given the relationship between persistent microcirculatory dysfunction 
and adverse outcome, targets for resuscitation in the future are likely to involve micro-
circulatory recruitment and ‘defense’ of tissue oxygenation. Several research groups are 
exploring new resuscitation strategies that focus on this area (7).
To date the literature on the prognostic value of microcirculatory observations is still 
scarce and mainly concerns sepsis. Sepsis is regarded as a disease of the microcirculation 
(6, 21, 31, 36-38), whereas in other diseases the role of the microcirculation has as yet not 
been extensively explored.
In our study about the eff ect of ECMO treatment (chapters 5 and 6), we compared 
critically ill neonates who received ECMO to those who did not receive this treatment. 
There was no diff erence in FCD between the two groups before the start of ECMO. The 
group that received ECMO treatment was regarded as sicker, but their condition was not 
refl ected by microcirculatory values of the buccal mucosa. Therefore, these observations 
do not seem to have a predictive value for the need for ECMO.
The positive eff ect on the microcirculation during and after the treatment with ECMO 
did not seem to have prognostic value for outcome. However, the studies described in 
chapters 5 and 6 were not designed to compare outcomes. Patients in the ECMO treated 
group were sicker and therefore eligible for ECMO treatment. Further research is needed 
to investigate diff erences between survivors and non-survivors of ECMO treatment. It is 
obvious that microvascular parameters should not be interpreted separate from the dis-
ease specifi c context or the applied therapy. In addition, they should not be uncoupled 
from macrocirculatory parameters and other values that provide information about 
tissue oxygenation and adequate cell function, such as lactate.
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FUTURE PERSPECTIVES
The fundamental role played by the microcirculation in regulating oxygen delivery 
supports the belief that alterations in microvascular perfusion are implicated in both 
organ dysfunction and multiple organ failure due to shock from a variety of etiologies 
(39). Clearly, maintenance of adequate tissue oxygenation should be considered as a 
fundamental objective of any intensive care resuscitation strategy. Ideally, we should 
be able to reliably, accurately and reproducibly measure oxygen supply and utilization 
in specifi c tissues at the bedside. Measuring microcirculatory fl ow as a prerequisite for 
tissue oxygenation and the integrity of the microcirculation can be highly valuable. As 
bedside assessment, it can be a sensitive marker for physiological circulatory derange-
ment in shocked, critically unwell patients.
Although observations of the sublingual and buccal mucosa have been proven to 
be valuable, they may not necessarily correlate with the microcirculatory fl ow in other 
organs with their diff erent microcirculation structure and function (31, 40, 41). A key 
characteristic of microcirculatory dysfunction in sepsis is the marked heterogeneity 
of the blood fl ow and hyperperfused capillaries adjacent to hypoperfused capillaries. 
To date, however, it is unclear if the same applies to other disease states. Functionally 
impaired focal microcirculatory units are believed to invoke local hypoxia, leading to 
reversible or irreversible tissue damage (42). Thus, the severity of these events could 
potentially dictate the extent of mitochondrial dysfunction leading to organ failure (32).
It is clear that observations of the microcirculation are valuable. They provide informa-
tion about blood fl ow on tissue level and therefore insight into one of the crucial factors 
for oxygen delivery. This is in contrast to most macrocirculatory values which are based 
on pressure and do not provide information about fl ow. As stated in the introduction to 
this thesis, monitoring cardiac output in children has its limitations. Therefore, acquir-
ing information about microcirculatory fl ow with a relatively non-invasive tool can be 
considered as a big step forward in the hemodynamic monitoring of the critically ill pe-
diatric patient. Study of the microcirculation could also elucidate potential mechanisms 
of disease, something that is implied but not fully addressed in the current studies. 
Changes in local tissue perfusion do matter, even though global hemodynamic changes 
due to disease or in response to therapy can be more subtle.
Clinicians treating critically ill patients should realize that there is no straightforward 
relationship between macrocirculatory and microcirculatory hemodynamics, but that 
there are some independent determinants of fl ow in the diff erent circulatory beds. In 
addition, there is clearly individual variability. A recent study examining the eff ect of 
varying perfusion pressure with norepinephrine on responses of the sublingual micro-
circulation found no eff ect on the population as a whole, but a fair amount of variation 
in individual responses, with patients reaching maximal perfusion at diff erent mean 
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arterial pressures (43). This study also lends credence to the notion that evaluation of the 
perfusion of the microcirculation may be worthwhile as a clinical index of the adequacy 
of fl uid resuscitation in individual patients (44).
The clinical art remains, fi rstly, to monitor the right parameters and, secondly, to apply 
the right target values, which can vary according to age or underlying pathology and 
choice of therapy. Optimal macrocirculatory values in critical illness are not necessarily 
the same as normal values in health (45). It is reasonable to assume that the same applies 
for microvascular parameters. In addition, the approach to improve microcirculation 
should be disease specifi c. More research is warranted to explore the microcirculation 
in its (patho-) physiologic context and the diff erent factors infl uencing microcircula-
tory function. Randomized controlled trials are needed to investigate current treatment 
strategies and develop strategies to rescue the microcirculation.
To date, visualization of the buccal circulation is not quite ready for routine clinical 
application at the bedside. As it evolves, this technology needs to become more user 
friendly; there is room for improvement in both ease of acquisition and analysis to 
facilitate generation of reproducible and timely data to guide patient management (46). 
 
CONCLUSION
The importance of microvascular perfusion is well appreciated, yet it remains elusive. 
Direct observation of the microcirculation could be a valuable addition to the arsenal 
of hemodynamic monitoring tools for the critically ill patient. Especially in the pediatric 
population, where other monitoring modalities are limited, this could be useful. If the 
current practical limitations for routine use of OPS and SDF imaging can be overcome, 
such monitoring modalities may improve outcome by directing clinicians to administer-
ing resuscitative therapies in a more timely and eff ective  manner.  
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 SUMMARY 
The aims of this thesis were to assess the feasibility of orthogonal polarization spectral 
(OPS) imaging of the buccal microcirculation in children and to investigate the eff ect of 
disease and critical care treatments on microcirculatory hemodynamics. To fulfi l these 
aims two groups of children were studied: those with presumably normal microcircula-
tion and those who were critically ill with severe respiratory failure or with sepsis.
Routine hemodynamic monitoring in critically ill pediatric patients has limitations. 
Restoration of global hemodynamics does not always mean that adequate regional 
tissue perfusion is achieved, especially in conditions of impaired autoregulation such 
as occurs during critical illness. The microcirculation is an essential hemodynamic com-
partment and as such plays an important role in (patho-) physiology of the circulation. 
Taken together, monitoring the microcirculation, possibly, could be a valuable addition 
to the hemodynamic monitoring of the critically ill pediatric patient.
In chapter 2, the results of investigations in children with a presumably normal mi-
crocirculation are presented. This study shows the feasibility of the technique in young 
children. Developmental changes in the structure of the microcirculation occur in the 
fi rst few weeks of life in healthy neonates. Consistent with a decrease of cutaneous 
functional capillary density (FCD) observed in premature infants in the fi rst month of 
life, we found that FCD of the buccal mucosa decreases after the fi rst week of neonatal 
life. The results of these observations can serve as reference data for future studies of the 
microcirculation in children. 
In chapter 3, the fi rst observations of the microcirculation of the buccal mucosa 
in a patient with meningococcal septic shock by using OPS imaging are described. It 
confi rmed that the microcirculation was altered in a critically ill child with septic shock. 
Follow-up measurements were performed during the fi rst 24 hours to observe eff ects of 
treatment on the microcirculation. After fl uid resuscitation and the start of inotropes and 
vasopressors, the microvascular parameters were stable. After the start of nitroglycerin, 
a donor of nitric oxide (NO), which is a vasodilator, recruitment of capillaries was seen.
Inhaled Nitric oxide (iNO) is a frequently used therapy in neonatal and pediatric inten-
sive care, especially in neonates with pulmonary hypertension. In chapter 4, the results 
of a study of the eff ect of iNO on the systemic microcirculation, by OPS imaging of the 
buccal mucosa, in infants with hypoxemic respiratory failure and PPHN are presented. 
The FCD of the buccal mucosa increased after the start of iNO, which supports the idea 
of a remote eff ect of iNO on distal vascular beds. 
Chapter 5 shows the results of a study in neonates with severe respiratory failure, 
who received extracorporeal membrane oxygenation (ECMO) treatment. The microcir-
culatory values in critically ill patients with severe respiratory failure were found to be 
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depressed. After treatment with ECMO, at a time when the patient no longer needed 
ECMO, the microcirculatory parameters were improved.
Direct eff ects of initiation of ECMO therapy are described in chapter 6. Surprisingly, 
the microcirculation did not improve immediately after the start of ECMO treatment. 
Nonetheless, FCD was preserved in patients who received ECMO treatment, while 
a deterioration of microvascular values was observed in the control group. There are 
several potential explanations for the lack of improvement of the microcirculation 
immediately after the start of ECMO, such as side eff ects of the ECMO treatment, e.g. 
infl ammatory response or disturbance of physiologic blood fl ow. Future studies should 
include folllow-up investigations and comparison of survivors and non-survivors. In this 
way, the prognostic value of microcirculatory parameters can be determined.
In chapter 7, the results of an observational study in pediatric patients with septic 
shock are described. These patients appeared to have reduced FCD, which is consistent 
with observations in adult patients. It was found that persistent alterations of the mi-
crocirculation were associated with poor outcome in children with septic shock. Lack of 
restoration of the altered microcirculation proved to have a stronger predictive value for 
mortality than the PRISM, a severity of illness score.
Chapter 8 contains the general discussion of this thesis. The currently available lit-
erature in addition to the contents of this thesis is reviewed and presented with future 
perspectives.
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SAME NVATTING
In dit proefschrift werd de toepasbaarheid van orthogonal polarization spectral (OPS) 
imaging voor het visualiseren van de microcirculatie bij kinderen onderzocht. Daarnaast 
werd het eff ect van ernstige ziekte en behandeling op de doorbloeding van de micro-
circulatie geevalueerd. Hiervoor werden verschillende patiënten groepen bestudeerd, 
namelijk kinderen van wie aangenomen werd dat zij een normale microcirculatie had-
den en kritisch zieke kinderen met ernstig respiratoir falen en kinderen met sepsis. 
De standaard toegepaste monitorbewaking van kritisch zieke kinderen heeft beper-
kingen. Het corrigeren van macrocirculatoire parameters parameters, zoals bloeddruk, 
is niet altijd een garantie voor adequate doorbloeding van de organen en weefsels.  Met 
name niet wanneer autoregulatie van de bloedcirculatie verstoord is zoals bij sommige 
ernstige ziekten. De microcirculatie speelt een belangrijke rol in de (patho-) fysiologie 
van de bloedcirculatie. Zodoende zou het monitoren van de microcirculatie , een mo-
gelijk waardevolle aanvulling kunnen zijn op de huidig gebruikte monitorbewaking van 
kritische zieke kinderen.
In hoofdstuk 2 worden de resultaten gepresenteerd van het bestuderen van de 
microcirculatie bij jonge kinderen, van wie aangenomen werd dat zij een normale 
microcirculatie hadden. In de eerste weken na de geboorte verandert de microcirculatie 
bij gezonde pasgeborenen. De belangrijkste bevinding was dat de functional capillary 
density (FCD) afneemt na de eerste levensweek. Dit onderzoek laat de toepasbaarheid 
van de techniek in kinderen zien. De resultaten kunnen gebruikt worden als referentie-
waarden voor toekomstige studies naar de microcirculatie in kinderen.
Hoofdstuk 3 beschrijft een case report over een patiënt met shock op basis van 
meningococcen sepsis. Bij deze patient werd de microcirculatie met behulp van OPS 
imaging  geëvalueerd. De eerste dag na opname werden OPS metingen verricht op 
verschillende tijdstip en het eff ect van de behandeling werd geëvalueerd. Na vochtsup-
pletie en de start van vasoactieve medicatie, waren microcirculatoire parameters stabiel. 
Na de introductie van nitroglycerine, een stikstofoxide (NO)- donor, werd toename van 
de vaatdichtheid in de microcirculatie waargenomen.
NO inhalatie (iNO) is een frequent toegepaste therapie in de neonatale en pediatrische 
intensive care, in het bijzonder in neonaten met pulmonale hypertensie. In hoofdstuk 
4 worden de resultaten gepresenteerd van een studie naar het eff ect van iNO op de sys-
temische microcirculatie, gemeten in het wangslijmvlies door middel van OPS imaging, 
bij kinderen met hypoxemisch respiratoir falen en persisterende pulmonale hypertensie 
van de neonaat (PPHN). De FCD in het wangslijmvlies nam toe na de start van iNO. Dit 
ondersteunt het idee, dat NO via het bloed wordt getransporteerd en eff ect kan hebben 
op andere vaatbedden buiten de long.
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Hoofdstuk 5 laat de resultaten zien van een studie bij neonaten met ernstig respiratoir 
falen, die behandeld werden met extracorporele membraan oxygenatie (ECMO). Deze 
patiënten hadden een verlaagde FCD bij aanvang van ECMO behandeling. Na afl oop 
van de ECMO behandeling waren de microcirculatoire parameters verbeterd.
Directe eff ecten van ECMO behandeling bij kritische zieke neonaten met ernstig resp-
piratoir falen worden beschreven in hoofdstuk 6. In tegenstelling tot de verwachting, 
verbeterde de microcirculatie niet direct na de start van ECMO. FCD was stabiel in de 
patiënten die behandeld werden met ECMO, terwijl een verslechtering werd waarge-
nomen in de controle groep, die bestond uit kinderen met ernstig respiratoir falen, die 
geen ECMO behandeling ontvingen. Het uitblijven van een herstel van de microcircula-
tie zou verklaard kunnen worden door een bijwerking van het ECMO systeem (bijvoor-
beeld de infl ammatoire reactie die ontstaat na de start of verstoring van fysiologische 
bloedstroom). Meer onderzoek is nodig om de ontwikkeling van microcirculatoire 
veranderingen tijdens deze behandeling in kaart te brengen en om de prognostische 
waarde van deze observaties te bepalen.
In hoofdstuk 7 worden de resultaten van een observationele studie in pediatrische 
patiënten met septische shock beschreven. Deze patiënten bleken een verlaagde FCD 
te hebben, hetgeen in overeenstemming is met observaties in volwassen patiënten. 
Het persisteren van een verlaagde FCD bleek geassocieerd te zijn met een slechtere 
prognose in kinderen met septische shock. Het uitblijven van verbetering van de mi-
crocirculatie bleek een sterkere voorspellende waarde te hebben dan de PRISM-score 
(pediatric risk of mortality score).
Hoofdstuk 8 bevat de algemene discussie. Een overzicht van de beschikbare litera-
tuur, in relatie tot de bevindingen in dit proefschrift, wordt besproken en aanbevelingen 
voor de toekomst worden gepresenteerd.
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LIST OF ABBREVIATIONS
ARDS Acute respiratory distress syndrome
AUC  Area under the curve
AVI  Audio video interleave
CCAM Congenital cystic adenomatoid malformation
CDH  Congenital diaphragmatic hernia
CI  Cardiac index
CMV  Conventional mandatory ventilation
CO  Cardiac output
CO2  Carbondioxide
CPB  Cardiopulmonary bypass
CRT  Capillary refi ll time
CVL  Central venous line
ΔFCD Change in functional capillary density
ΔpO2 Change in oxygen pressure
DO2  Delivery of oxygen
ECMO Extracorporeal membrane oxygenation
FCD  Functional capillary density
Hb  Hemoglobin
HFO  High frequency oscillation
HI  Heterogeneity index
ICU  Intensive care unit
INO  Inhaled nitric oxide
MAS  Meconium aspiration syndrome
MFI  Microvascular fl ow index
MODS Multiple organ dysfunction syndrome
MOF  Multiple organ failure
NO  Nitric oxide
OI  Oxygenation index
OPS  Orthogonal polarization Spectral
PDA  Patent ductus arteriosus
pO2  Oxygen pressure
PPHN Persistent pulmonary hypertension of the neonate
Ppm  Parts per million
PRISM Pediatric risk of mortality
PVR  Pulmonary vascular resistance
ROC  Receiver operator characteristic
SaO2 Arterial oxygen saturation
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SDF  Side stream darkfi eld 
SIRS  Severe infl ammatory response syndrome
SO2  Oxygen saturation
SOFA Sequential organ failure assessment
SpO2 Pulse oxymetry
SPSS Statistical Package for the Social Sciences
SVI  Stroke volume index
SvO2 Mixed venous oxygen saturation
SVR  Systemic vascular resistance
VA-ECMO Veno-arterial extracorporeal membrane oxygenation
VDI  Vessel density index
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The aims of this thesis were to assess the feasibility of orthogonal polarization 
spectral (OPS) imaging of the buccal microcirculation in children and to 
investigate the effect of disease and critical care treatments on microcirculatory 
hemodynamics. To fulfil these aims two groups of children were studied: those 
with presumably normal microcirculation and those who were critically ill with 
severe respiratory failure or with sepsis.
Routine hemodynamic monitoring in critically ill pediatric patients has 
limitations. Restoration of global hemodynamics does not always mean 
that adequate regional tissue perfusion is achieved, especially in conditions 
of impaired autoregulation such as occurs during critical illness. The 
microcirculation is an essential hemodynamic compartment and as such plays 
an important role in (patho-) physiology of the circulation. Taken together, 
monitoring the microcirculation, possibly, could be a valuable addition to the 
hemodynamic monitoring of the critically ill pediatric patient.
